Annotation Detail for ABCC1
Basic Information Top
| Gene Symbol: | ABCC1 ( ABC29,ABCC,DKFZp686N04233,DKFZp781G125,GS-X,MRP,MRP1 ) |
|---|---|
| Gene Full Name: | ATP-binding cassette, sub-family C (CFTR/MRP), member 1 |
| Band: | 16p13.11 |
| Quick Links | Entrez ID:4363; OMIM: 158343; Uniprot ID:MRP1_HUMAN; ENSEMBL ID: ENSG00000103222; HGNC ID: 51 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| hsa02010 | ABC transporters |
| Pathway ID | Pathway Name |
|---|---|
| Hormone biosynthesis | |
| Metabolism of lipids and lipoproteins |
| Pathway ID | Pathway Name |
|---|---|
| 200071 | S1P1 pathway |
| 200104 | Sphingosine 1-phosphate (S1P) pathway |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| 500771 | Leukotriene synthesis |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C097240 | 15-deoxy-delta(12,14)-prostaglandin J2 | ABCC1 protein affects the export of 15-deoxy-delta(12,14)-prostaglandin J2 analog | affects export | 14979731 |
| C021310 | 2-(4'-maleimidylanilino)naphthalene-6-sulfonic acid | 2-(4'-maleimidylanilino)naphthalene-6-sulfonic acid binds to and results in decreased activity of ABCC1 protein | affects binding|decreases activity | 15623154 |
| C023514 | 2,6-dinitrotoluene | 2,6-dinitrotoluene affects the expression of ABCC1 mRNA | affects expression | 21346803 |
| C473073 | 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [ABCC1 protein results in increased transport of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein] | decreases reaction|increases transport | 16827148 |
| C473073 | 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein | ABCC1 protein results in increased transport of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein | increases transport | 16827148 |
| C473073 | 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein | alpha-viniferin inhibits the reaction [ABCC1 protein results in increased transport of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein] | decreases reaction|increases transport | 16827148 |
| C473073 | 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein | epsilon-viniferin inhibits the reaction [ABCC1 protein results in increased transport of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein] | decreases reaction|increases transport | 16827148 |
| C028405 | 2-naphthol | ABCC1 protein affects the sulfation of 2-naphthol | affects sulfation | 14742140 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of ABCC1 mRNA | increases expression | 11836020 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of ABCC1 protein | increases expression | 11836020 |
| C018855 | 2-tert-butylhydroquinone | 2-tert-butylhydroquinone results in increased expression of ABCC1 mRNA | increases expression | 16014739 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | 3,3',4,5'-tetrahydroxystilbene inhibits the reaction [ABCC1 protein results in increased transport of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein] | decreases reaction|increases transport | 16827148 |
| C041525 | 3,3',4,5'-tetrahydroxystilbene | 3,3',4,5'-tetrahydroxystilbene results in decreased activity of ABCC1 protein | decreases activity | 16827148 |
| C028288 | 3',4'-dihydroxyflavone | 3',4'-dihydroxyflavone results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| C047368 | 3-methylquercetin | 3-methylquercetin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| C009505 | 4,4'-diaminodiphenylmethane | 4,4'-diaminodiphenylmethane results in increased expression of ABCC1 mRNA | increases expression | 18648102 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal binds to ABCC1 protein | affects binding | 15672542 |
| C099564 | 4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid | ABCC1 protein results in increased transport of 4-((methylnitrosoamino)-1-(3-pyridyl)but-1-yl)beta-omega-glucosiduronic acid | increases transport | 17724374 |
| C024836 | 4-nitrophenol | ABCC1 protein affects the glucuronidation of 4-nitrophenol | affects glucuronidation | 14742140 |
| C066668 | 5,6-dimethylxanthenoneacetic acid | ABCC1 protein affects the export of 5,6-dimethylxanthenoneacetic acid metabolite | affects export | 15784341 |
| C066668 | 5,6-dimethylxanthenoneacetic acid | ABCC1 protein affects the transport of 5,6-dimethylxanthenoneacetic acid analog | affects transport | 15282097 |
| C103111 | 5,7,3',4'-tetramethylluteolin | 5,7,3',4'-tetramethylluteolin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| C084577 | 5-carboxyfluorescein diacetate | ABCC1 protein affects the export of 5-carboxyfluorescein diacetate | affects export | 15744065 |
| C084577 | 5-carboxyfluorescein diacetate | Cyclosporine inhibits the reaction [ABCC1 protein affects the export of 5-carboxyfluorescein diacetate] | affects export|decreases reaction | 16636798 |
| C084577 | 5-carboxyfluorescein diacetate | Indomethacin inhibits the reaction [ABCC1 protein affects the export of 5-carboxyfluorescein diacetate] | affects export|decreases reaction | 16636798 |
| C084577 | 5-carboxyfluorescein diacetate | Verapamil inhibits the reaction [ABCC1 protein affects the export of 5-carboxyfluorescein diacetate] | affects export|decreases reaction | 16636798 |
| C024098 | 6-carboxyfluorescein | ABCC1 protein results in increased export of 6-carboxyfluorescein | increases export | 17940500 |
| C017040 | 8-azidoadenosine 5'-triphosphate | 8-azidoadenosine 5'-triphosphate binds to ABCC1 protein | affects binding | 14978246 |
| C017040 | 8-azidoadenosine 5'-triphosphate | ABCC1 protein binds to 8-azidoadenosine 5'-triphosphate | affects binding | 16156793 |
| C017040 | 8-azidoadenosine 5'-triphosphate | Disulfiram inhibits the reaction [8-azidoadenosine 5'-triphosphate binds to ABCC1 protein] | affects binding|decreases reaction | 14978246 |
| C017040 | 8-azidoadenosine 5'-triphosphate | Vanadates promotes the reaction [8-azidoadenosine 5'-triphosphate binds to ABCC1 protein] | affects binding|increases reaction | 12069597 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of ABCC1 mRNA | increases expression | 17627974 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of ABCC1 mRNA | affects expression | 17562736 |
| D000082 | Acetaminophen | [Acetaminophen co-treated with Sodium Chloride] results in increased expression of ABCC1 mRNA | affects cotreatment|increases expression | 17934960 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of ABCC1 mRNA | increases expression | 17935745 15496496 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of ABCC1 protein | increases expression | 17935745 |
| C043377 | acetochlor | ABCC1 protein results in increased export of acetochlor metabolite | increases export | 18433974 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC1 protein] | decreases reaction|increases expression | 11820781 |
| D000111 | Acetylcysteine | Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases response to substance|increases reaction | 15473893 |
| D000111 | Acetylcysteine | Buthionine Sulfoximine analog inhibits the reaction [Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]] | decreases reaction|decreases response to substance|increases reaction | 15473893 |
| D000255 | Adenosine Triphosphate | ABCC1 protein binds to and results in increased degradation of Adenosine Triphosphate | affects binding|increases degradation | 15459206 |
| D000255 | Adenosine Triphosphate | ABCC1 protein binds to and results in increased hydrolysis of Adenosine Triphosphate | affects binding|increases hydrolysis | 14978246 |
| D000255 | Adenosine Triphosphate | ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate | increases hydrolysis | 16156793 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate binds to ABCC1 protein | affects binding | 15355964 15737336 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate binds to and affects the folding of ABCC1 protein | affects binding|affects folding | 15838832 11278000 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate promotes the reaction [ABCC1 protein affects the transport of Bilirubin] | affects transport|increases reaction | 15245331 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate promotes the reaction [ABCC1 protein affects the transport of estradiol-17 beta-glucuronide] | affects transport|increases reaction | 15459206 |
| D000255 | Adenosine Triphosphate | Adenosine Triphosphate promotes the reaction [ABCC1 protein affects the transport of Leukotriene C4] | affects transport|increases reaction | 15355964 15459206 |
| D000255 | Adenosine Triphosphate | daidzein promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 16156793 |
| D000255 | Adenosine Triphosphate | Disulfiram affects the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | affects reaction|increases hydrolysis | 14978246 |
| D000255 | Adenosine Triphosphate | hesperetin promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 16156793 |
| D000255 | Adenosine Triphosphate | naringenin promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 16156793 |
| D000255 | Adenosine Triphosphate | Quercetin affects the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | affects reaction|increases hydrolysis | 16156793 |
| D000255 | Adenosine Triphosphate | resveratrol promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 16156793 |
| D000255 | Adenosine Triphosphate | Silymarin inhibits the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | decreases reaction|increases hydrolysis | 16156793 |
| D000255 | Adenosine Triphosphate | ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate | increases hydrolysis | 10856430 |
| D000255 | Adenosine Triphosphate | Daunorubicin promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 10856430 |
| D000255 | Adenosine Triphosphate | Vanadates inhibits the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | decreases reaction|increases hydrolysis | 10856430 |
| D000255 | Adenosine Triphosphate | [Adenosine Triphosphate binds to ABCC1 protein] inhibits the reaction [Leukotriene C4 binds to ABCC1 protein] | affects binding|decreases reaction | 15755910 |
| C080240 | afromosin | afromosin affects the activity of ABCC1 protein | affects activity | 15796199 |
| C064176 | alpha-viniferin | alpha-viniferin inhibits the reaction [ABCC1 protein results in increased transport of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein] | decreases reaction|increases transport | 16827148 |
| C064176 | alpha-viniferin | alpha-viniferin results in decreased activity of ABCC1 protein | decreases activity | 16827148 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of ABCC1 mRNA | affects expression | 16483693 |
| C010680 | antibiotic G 418 | ABCC1 protein results in increased transport of antibiotic G 418 | increases transport | 20018165 |
| D000965 | Antimony | ABCC1 protein results in decreased susceptibility to Antimony | decreases response to substance | 11560771 |
| D000965 | Antimony | GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony] | decreases reaction|decreases response to substance | 11560771 |
| D000966 | Antimony Potassium Tartrate | ABCC1 protein affects the susceptibility to Antimony Potassium Tartrate | affects response to substance | 12731862 |
| D000966 | Antimony Potassium Tartrate | ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate | decreases response to substance | 10025956 11278867 |
| D000966 | Antimony Potassium Tartrate | ABCC1 protein results in increased secretion of Antimony Potassium Tartrate | increases secretion | 10025956 12018890 |
| D000966 | Antimony Potassium Tartrate | Glutathione affects the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate] | affects reaction|increases secretion | 12018890 |
| D000966 | Antimony Potassium Tartrate | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Antimony Potassium Tartrate | affects expression|affects response to substance | 10348353 |
| D000966 | Antimony Potassium Tartrate | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate] | decreases reaction|decreases response to substance | 10025956 |
| D000966 | Antimony Potassium Tartrate | verlukast inhibits the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate] | decreases reaction|increases secretion | 10025956 |
| C102351 | apicidin | ABCC1 protein results in decreased susceptibility to apicidin | decreases response to substance | 16049968 |
| D047310 | Apigenin | Apigenin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| C526219 | apple polyphenol extract | apple polyphenol extract results in increased expression of ABCC1 mRNA | increases expression | 18351577 |
| D001151 | Arsenic | ABCC1 protein results in increased export of Arsenic | increases export | 12387749 |
| D001151 | Arsenic | Arsenic results in increased activity of ABCC1 protein | increases activity | 18487201 |
| D001151 | Arsenic | [Arsenic results in increased activity of ABCC1 protein] which results in increased export of Arsenic | increases activity|increases export | 18487201 |
| D001151 | Arsenic | Arsenic results in increased expression of ABCC1 mRNA | increases expression | 18487201 |
| C006632 | arsenic trioxide | ABCC1 protein results in decreased susceptibility to arsenic trioxide | decreases response to substance | 11331074 |
| C006632 | arsenic trioxide | ABCC1 protein results in increased secretion of arsenic trioxide | increases secretion | 12018890 |
| C006632 | arsenic trioxide | Glutathione affects the reaction [ABCC1 protein results in increased secretion of arsenic trioxide] | affects reaction|increases secretion | 12018890 |
| C006632 | arsenic trioxide | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to arsenic trioxide] | decreases reaction|decreases response to substance | 11331074 |
| C015001 | arsenite | ABCC1 protein affects the transport of [arsenite co-treated with Glutathione] | affects cotreatment|affects transport | 15161912 |
| C423185 | avasimibe | avasimibe results in increased expression of ABCC1 | increases expression | 15333513 |
| C006680 | baicalein | baicalein results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of ABCC1 mRNA | increases expression | 11752103 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of ABCC1 mRNA | decreases expression | 19150397 |
| D001663 | Bilirubin | ABCC1 protein affects the transport of Bilirubin | affects transport | 15245331 |
| D001663 | Bilirubin | Adenosine Triphosphate promotes the reaction [ABCC1 protein affects the transport of Bilirubin] | affects transport|increases reaction | 15245331 |
| D001663 | Bilirubin | Bilirubin inhibits the reaction [ABCC1 protein affects the transport of Leukotriene C4] | affects transport|decreases reaction | 15245331 |
| D001663 | Bilirubin | Glutathione promotes the reaction [ABCC1 protein affects the transport of Bilirubin] | affects transport|increases reaction | 15245331 |
| D001663 | Bilirubin | verlukast inhibits the reaction [ABCC1 protein affects the transport of Bilirubin] | affects transport|decreases reaction | 15245331 |
| C004541 | biochanin A | biochanin A results in decreased activity of ABCC1 protein | decreases activity | 15581599 |
| C034786 | bis(4-hydroxycinnamoyl)methane | bis(4-hydroxycinnamoyl)methane results in decreased activity of ABCC1 protein | decreases activity | 15885658 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine affects the localization of ABCC1 protein mutant form | affects localization | 15581632 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine analog inhibits the reaction [Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]] | decreases reaction|decreases response to substance|increases reaction | 15473893 |
| D019328 | Buthionine Sulfoximine | Buthionine Sulfoximine inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15180633 |
| C065566 | buthionine sulfoximine ethyl ester | ABCC1 protein results in increased susceptibility to buthionine sulfoximine ethyl ester | increases response to substance | 12504668 |
| C065566 | buthionine sulfoximine ethyl ester | buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased export of Glutathione] | increases export|increases reaction | 12504668 |
| C065566 | buthionine sulfoximine ethyl ester | buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased susceptibility to Chlorambucil] | increases reaction|increases response to substance | 12504668 |
| C065566 | buthionine sulfoximine ethyl ester | buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased susceptibility to Doxorubicin] | increases reaction|increases response to substance | 12504668 |
| C065566 | buthionine sulfoximine ethyl ester | GCLC protein inhibits the reaction [buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased export of Glutathione]] | decreases reaction|increases export|increases reaction | 12504668 |
| C065566 | buthionine sulfoximine ethyl ester | ABCC1 protein results in increased susceptibility to buthionine sulfoximine ethyl ester | increases response to substance | 12504668 |
| C065566 | buthionine sulfoximine ethyl ester | buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased export of Glutathione] | increases export|increases reaction | 12504668 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of ABCC1 mRNA | increases expression | 16436460 |
| D002101 | Cacodylic Acid | Cacodylic Acid results in increased expression of ABCC1 protein | increases expression | 16436460 |
| D002104 | Cadmium | ABCC1 protein results in decreased susceptibility to Cadmium | decreases response to substance | 8947035 |
| C055494 | caffeic acid phenethyl ester | caffeic acid phenethyl ester metabolite results in decreased activity of ABCC1 protein | decreases activity | 15885658 |
| C085925 | calcein AM | ABCC1 protein affects the export of calcein AM | affects export | 12516967 |
| D002166 | Camptothecin | ABCC1 protein results in decreased susceptibility to Camptothecin analog | decreases response to substance | 11778547 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of ABCC1 mRNA | increases expression | 15496496 17484886 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of ABCC1 protein | increases expression | 16177239 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of ABCC1 protein | increases expression | 17544377 |
| D002699 | Chlorambucil | ABCC1 protein affects the export of Chlorambucil analog | affects export | 14569069 11115505 |
| D002699 | Chlorambucil | ABCC1 protein results in decreased susceptibility to Chlorambucil | decreases response to substance | 11115505 10900222 |
| D002699 | Chlorambucil | ABCC1 protein results in increased susceptibility to Chlorambucil | increases response to substance | 12504668 |
| D002699 | Chlorambucil | buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased susceptibility to Chlorambucil] | increases reaction|increases response to substance | 12504668 |
| D002699 | Chlorambucil | GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Chlorambucil] | decreases response to substance|increases reaction | 10900222 |
| C084597 | chlorcyclizine | ABCC1 protein affects the transport of chlorcyclizine | affects transport | 15666293 |
| D002713 | Chlorine | [Ozone co-treated with Chlorine] results in decreased expression of ABCC1 mRNA | affects cotreatment|decreases expression | 18636392 |
| D002744 | Chlorpheniramine | ABCC1 protein affects the transport of Chlorpheniramine | affects transport | 15666293 |
| D002748 | Chlorpropham | ABCC1 protein results in decreased susceptibility to Chlorpropham | decreases response to substance | 12765240 |
| C007054 | chrysoeriol | chrysoeriol results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| D002990 | Clobetasol | Clobetasol results in decreased expression of ABCC1 mRNA | decreases expression | 16882163 |
| D003078 | Colchicine | ABCC1 protein results in decreased susceptibility to Colchicine | decreases response to substance | 12067707 |
| D003078 | Colchicine | ABCC1 protein results in decreased susceptibility to Colchicine | decreases response to substance | 12067707 |
| C515714 | copper (N-2-hydroxyacetophenone)glycinate | copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of ABCC1 protein | decreases expression | 17107616 16289015 |
| C515714 | copper (N-2-hydroxyacetophenone)glycinate | [copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of ABCC1 protein] which results in increased susceptibility to Doxorubicin | decreases expression|increases response to substance | 16289015 |
| D003474 | Curcumin | Curcumin results in decreased activity of ABCC1 protein | decreases activity | 16021489 15885658 |
| C475935 | curcumin III | curcumin III results in decreased activity of ABCC1 protein | decreases activity | 16021489 |
| D003520 | Cyclophosphamide | ABCC1 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 12576456 |
| D003520 | Cyclophosphamide | ABCC1 protein results in decreased susceptibility to Cyclophosphamide | decreases response to substance | 11778547 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [ABCC1 protein affects the export of 5-carboxyfluorescein diacetate] | affects export|decreases reaction | 16636798 |
| D016572 | Cyclosporine | Cyclosporine results in increased expression of ABCC1 mRNA | increases expression | 20106945 |
| D003524 | Cyclosporins | Cyclosporins affects the activity of ABCC1 protein | affects activity | 15788683 |
| D003561 | Cytarabine | ABCC1 protein affects the susceptibility to Cytarabine | affects response to substance | 17852453 |
| D003609 | Dactinomycin | ABCC1 protein results in decreased susceptibility to Dactinomycin | decreases response to substance | 12067707 |
| D003609 | Dactinomycin | ABCC1 protein results in decreased susceptibility to Dactinomycin | decreases response to substance | 12067707 |
| D003609 | Dactinomycin | ABCC1 protein results in decreased susceptibility to Dactinomycin | decreases response to substance | 11455017 |
| C004742 | daidzein | daidzein promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 16156793 |
| D003630 | Daunorubicin | ABCC1 protein affects the export of Daunorubicin | affects export | 15498506 |
| D003630 | Daunorubicin | ABCC1 protein results in decreased susceptibility to Daunorubicin | decreases response to substance | 12657726 |
| D003630 | Daunorubicin | PAK 104P inhibits the reaction [ABCC1 protein affects the export of Daunorubicin] | affects export|decreases reaction | 15498506 |
| D003630 | Daunorubicin | Verapamil inhibits the reaction [ABCC1 protein affects the export of Daunorubicin] | affects export|decreases reaction | 15498506 |
| D003630 | Daunorubicin | ABCC1 protein results in decreased susceptibility to Daunorubicin | decreases response to substance | 12657726 |
| D003630 | Daunorubicin | ABCC1 protein results in decreased uptake of Daunorubicin | decreases uptake | 10856430 |
| D003630 | Daunorubicin | Daunorubicin promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 10856430 |
| D003630 | Daunorubicin | Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]] | decreases reaction|decreases uptake | 10856430 |
| D003630 | Daunorubicin | Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin] | decreases reaction|decreases uptake | 10856430 |
| D003630 | Daunorubicin | Verapamil inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin] | decreases reaction|decreases uptake | 10856430 |
| C050229 | demethoxycurcumin | demethoxycurcumin results in decreased activity of ABCC1 protein | decreases activity | 15885658 16021489 |
| D015255 | Idarubicin | Idarubicin binds to and affects the folding of ABCC1 protein | affects binding|affects folding | 11278000 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of ABCC1 mRNA] | decreases reaction|increases expression | 15205389 |
| D002945 | Cisplatin | ABCC1 affects the susceptibility to Cisplatin | affects response to substance | 15756446 |
| D002945 | Cisplatin | ABCC1 mRNA results in decreased susceptibility to Cisplatin | decreases response to substance | 15448748 |
| D002945 | Cisplatin | [Cisplatin co-treated with Fluorouracil] results in decreased expression of ABCC1 mRNA | affects cotreatment|decreases expression | 17638652 |
| D002945 | Cisplatin | [PTGS2 protein results in increased expression of ABCC1 protein] which results in increased susceptibility to Cisplatin | increases expression|increases response to substance | 18695918 |
| D002945 | Cisplatin | ABCC1 protein results in decreased susceptibility to Cisplatin | decreases response to substance | 11455017 |
| C039602 | diosmetin | diosmetin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| D004221 | Disulfiram | Disulfiram affects the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | affects reaction|increases hydrolysis | 14978246 |
| D004221 | Disulfiram | Disulfiram inhibits the reaction [8-azidoadenosine 5'-triphosphate binds to ABCC1 protein] | affects binding|decreases reaction | 14978246 |
| D004221 | Disulfiram | Disulfiram results in decreased activity of ABCC1 protein | decreases activity | 14978246 |
| C067311 | docetaxel | docetaxel results in increased expression of ABCC1 protein | increases expression | 15239124 |
| D004317 | Doxorubicin | ABCC1 protein affects the transport of Doxorubicin | affects transport | 15581632 |
| D004317 | Doxorubicin | ABCC1 protein mutant form affects the transport of Doxorubicin | affects transport | 15581632 |
| D004317 | Doxorubicin | ABCC1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 15180633 11560771 15473893 17940500 10900222 12067707 11778547 12657726 |
| D004317 | Doxorubicin | ABCC1 protein results in increased susceptibility to Doxorubicin | increases response to substance | 12504668 |
| D004317 | Doxorubicin | ABCC1 results in decreased susceptibility to Doxorubicin | decreases response to substance | 15548710 |
| D004317 | Doxorubicin | Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases response to substance|increases reaction | 15473893 |
| D004317 | Doxorubicin | Buthionine Sulfoximine analog inhibits the reaction [Acetylcysteine promotes the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin]] | decreases reaction|decreases response to substance|increases reaction | 15473893 |
| D004317 | Doxorubicin | buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased susceptibility to Doxorubicin] | increases reaction|increases response to substance | 12504668 |
| D004317 | Doxorubicin | Doxorubicin inhibits the reaction [ABCC1 protein affects the transport of Vincristine] | affects transport|decreases reaction | 10685512 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [JUN protein binds to ABCC1 promoter] | affects binding|increases reaction | 15880572 |
| D004317 | Doxorubicin | [Doxorubicin results in decreased expression of ABCC1 mRNA] which results in increased susceptibility to Indomethacin | decreases expression|increases response to substance | 16331495 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of ABCC1 mRNA | increases expression | 18560228 17852453 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of ABCC1 protein | increases expression | 15880572 |
| D004317 | Doxorubicin | GCLC protein inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 11560771 |
| D004317 | Doxorubicin | Haloperidol inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 15946544 |
| D004317 | Doxorubicin | Heparin affects the reaction [ABCC1 protein affects the transport of Doxorubicin] | affects reaction|affects transport | 17352253 |
| D004317 | Doxorubicin | Indomethacin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 17940500 |
| D004317 | Doxorubicin | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Doxorubicin | affects expression|affects response to substance | 10348353 |
| D004317 | Doxorubicin | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 15180633 |
| D004317 | Doxorubicin | ABCC1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 12657726 |
| D004317 | Doxorubicin | ABCC1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 16289015 |
| D004317 | Doxorubicin | [copper (N-2-hydroxyacetophenone)glycinate results in decreased expression of ABCC1 protein] which results in increased susceptibility to Doxorubicin | decreases expression|increases response to substance | 16289015 |
| D004317 | Doxorubicin | ABCC1 protein results in decreased susceptibility to Doxorubicin | decreases response to substance | 11455017 |
| D015251 | Epirubicin | ABCC1 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 12576456 |
| D015251 | Epirubicin | ABCC1 protein results in decreased susceptibility to Epirubicin | decreases response to substance | 12657726 |
| D015251 | Epirubicin | ABCC1 protein results in decreased susceptibility to Epirubicin | decreases response to substance | 12657726 |
| C091891 | epsilon-viniferin | epsilon-viniferin inhibits the reaction [ABCC1 protein results in increased transport of 2',7'-bis-(carboxypropyl)-5(6)-carboxyfluorescein] | decreases reaction|increases transport | 16827148 |
| C091891 | epsilon-viniferin | epsilon-viniferin results in decreased activity of ABCC1 protein | decreases activity | 16827148 |
| C007619 | eriodictyol | eriodictyol results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| C025483 | estradiol-17 beta-glucuronide | ABCC1 protein affects the transport of estradiol-17 beta-glucuronide | affects transport | 11278867 |
| C025483 | estradiol-17 beta-glucuronide | Adenosine Triphosphate promotes the reaction [ABCC1 protein affects the transport of estradiol-17 beta-glucuronide] | affects transport|increases reaction | 15459206 |
| C025483 | estradiol-17 beta-glucuronide | estradiol-17 beta-glucuronide inhibits the reaction [ABCC1 protein affects the transport of Leukotriene C4] | affects transport|decreases reaction | 11278867 |
| D004958 | Estradiol | Estradiol results in decreased expression of ABCC1 mRNA | decreases expression | 11080590 |
| D004967 | Estrogens | Estrogens results in decreased expression of ABCC1 mRNA | decreases expression | 11080590 |
| D004976 | Ethacrynic Acid | ABCC1 protein results in decreased susceptibility to Ethacrynic Acid | decreases response to substance | 10900222 |
| D004976 | Ethacrynic Acid | GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Ethacrynic Acid] | decreases response to substance|increases reaction | 10900222 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of ABCC1 mRNA | affects expression | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of ABCC1 mRNA | increases expression | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCC1 mRNA | affects cotreatment|increases expression | 17942748 |
| D005047 | Etoposide | ABCC1 protein results in decreased susceptibility to Etoposide | decreases response to substance | 12067707 |
| D005047 | Etoposide | ABCC1 protein results in decreased susceptibility to Etoposide | decreases response to substance | 12516967 |
| D005047 | Etoposide | ABCC1 protein affects the susceptibility to Etoposide | affects response to substance | 16217747 |
| D005047 | Etoposide | ABCC1 protein results in decreased susceptibility to Etoposide | decreases response to substance | 16156793 15999103 11778547 10900222 15180633 |
| D005047 | Etoposide | ABCC1 results in decreased susceptibility to Etoposide | decreases response to substance | 15460906 |
| D005047 | Etoposide | [GCLC protein co-treated with GCLM protein] promotes the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | affects cotreatment|decreases response to substance|increases reaction | 10900222 |
| D005047 | Etoposide | GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases response to substance|increases reaction | 10900222 |
| D005047 | Etoposide | hesperetin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 |
| D005047 | Etoposide | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Etoposide | affects expression|affects response to substance | 10348353 |
| D005047 | Etoposide | naringenin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 |
| D005047 | Etoposide | resveratrol inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 |
| D005047 | Etoposide | Silymarin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 |
| D005047 | Etoposide | Tocopherols inhibits the reaction [ABCC1 protein affects the export of Etoposide] | affects export|decreases reaction | 15617835 |
| D005047 | Etoposide | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 15180633 |
| D005047 | Etoposide | ABCC1 protein results in decreased susceptibility to Etoposide | decreases response to substance | 12657726 |
| D005047 | Etoposide | ABCC1 protein results in decreased susceptibility to Etoposide | decreases response to substance | 10856430 |
| D005047 | Etoposide | ABCC1 protein results in decreased uptake of Etoposide | decreases uptake | 10856430 |
| D005047 | Etoposide | Etoposide results in increased expression of ABCC1 mRNA | increases expression | 10856430 |
| D005047 | Etoposide | Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide]] | decreases reaction|decreases uptake | 10856430 |
| D005047 | Etoposide | Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide] | decreases reaction|decreases uptake | 10856430 |
| D005047 | Etoposide | Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 10856430 |
| D005047 | Etoposide | Verapamil inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide] | decreases reaction|decreases uptake | 10856430 |
| D005278 | Fenitrothion | ABCC1 protein results in decreased susceptibility to Fenitrothion | decreases response to substance | 12765240 |
| C020326 | ferric nitrilotriacetate | ferric nitrilotriacetate results in increased expression of ABCC1 mRNA | increases expression | 18617210 |
| C043562 | flavone | flavone inhibits the reaction [ABCC1 protein affects the export of S-(2,4-dinitrophenyl)glutathione] | affects export|decreases reaction | 15041478 |
| C043562 | flavone | flavone results in decreased activity of ABCC1 protein | decreases activity | 15041478 |
| D005419 | Flavonoids | Flavonoids analog results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| D005419 | Flavonoids | Flavonoids results in decreased activity of ABCC1 protein | decreases activity | 15916776 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of ABCC1 mRNA | decreases expression | 15465739 |
| D005419 | Flavonoids | Flavonoids results in decreased expression of ABCC1 protein | decreases expression | 15465739 |
| C059715 | Fluo-3 | ABCC1 protein affects the export of Fluo-3 | affects export | 15948026 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of ABCC1 mRNA | increases expression | 17669244 12801967 |
| C007740 | fluorexon | ABCC1 protein affects the export of fluorexon | affects export | 15670588 |
| C007740 | fluorexon | ABCC1 protein affects the transport of fluorexon | affects transport | 10685512 15670588 |
| C007740 | fluorexon | ABCC1 protein results in increased export of fluorexon | increases export | 16156793 |
| C007740 | fluorexon | Mefloquine inhibits the reaction [ABCC1 protein affects the export of fluorexon] | affects export|decreases reaction | 16004972 |
| C007740 | fluorexon | Quercetin inhibits the reaction [ABCC1 protein results in increased export of fluorexon] | decreases reaction|increases export | 16156793 |
| C007740 | fluorexon | robinetin inhibits the reaction [ABCC1 protein affects the export of fluorexon] | affects export|decreases reaction | 15670588 |
| C007740 | fluorexon | Silymarin inhibits the reaction [ABCC1 protein results in increased export of fluorexon] | decreases reaction|increases export | 16156793 |
| C007740 | fluorexon | verlukast inhibits the reaction [ABCC1 protein affects the export of fluorexon] | affects export|decreases reaction | 16004972 |
| C007740 | fluorexon | verlukast inhibits the reaction [ABCC1 protein results in increased export of fluorexon] | decreases reaction|increases export | 16156793 |
| C007740 | fluorexon | Vincristine inhibits the reaction [ABCC1 protein affects the transport of fluorexon] | affects transport|decreases reaction | 10685512 |
| D005472 | Fluorouracil | ABCC1 protein affects the susceptibility to [Fluorouracil co-treated with Epirubicin co-treated with Cyclophosphamide] | affects cotreatment|affects response to substance | 12576456 |
| D005472 | Fluorouracil | [Cisplatin co-treated with Fluorouracil] results in decreased expression of ABCC1 mRNA | affects cotreatment|decreases expression | 17638652 |
| D005492 | Folic Acid | Folic Acid affects the expression of ABCC1 protein | affects expression | 15657365 |
| C007768 | formononetin | formononetin affects the activity of ABCC1 protein | affects activity | 15796199 |
| C037032 | galangin | galangin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| C057580 | gallocatechol | gallocatechol affects the activity of ABCC1 protein | affects activity | 15796199 |
| D019833 | Genistein | Genistein analog results in decreased activity of ABCC1 protein | decreases activity | 15916776 |
| D019833 | Genistein | Genistein results in decreased activity of ABCC1 protein | decreases activity | 15581599 |
| D019833 | Genistein | Genistein results in decreased activity of ABCC1 protein | decreases activity | 12893836 |
| D019833 | Genistein | [Genistein results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| D005947 | Glucose | Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]] | decreases reaction|decreases uptake | 10856430 |
| D005947 | Glucose | Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide]] | decreases reaction|decreases uptake | 10856430 |
| D005978 | Glutathione | ABCC1 protein affects the export of Glutathione | affects export | 15498506 |
| D005978 | Glutathione | ABCC1 protein affects the transport of [arsenite co-treated with Glutathione] | affects cotreatment|affects transport | 15161912 |
| D005978 | Glutathione | ABCC1 protein affects the transport of Glutathione | affects transport | 11278867 |
| D005978 | Glutathione | ABCC1 protein results in increased export of Glutathione | increases export | 12504668 |
| D005978 | Glutathione | buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased export of Glutathione] | increases export|increases reaction | 12504668 |
| D005978 | Glutathione | GCLC protein inhibits the reaction [buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased export of Glutathione]] | decreases reaction|increases export|increases reaction | 12504668 |
| D005978 | Glutathione | Glutathione affects the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate] | affects reaction|increases secretion | 12018890 |
| D005978 | Glutathione | Glutathione affects the reaction [ABCC1 protein results in increased secretion of arsenic trioxide] | affects reaction|increases secretion | 12018890 |
| D005978 | Glutathione | Glutathione binds to and affects the folding of and affects the activity of ABCC1 protein | affects activity|affects binding|affects folding | 15579473 |
| D005978 | Glutathione | Glutathione promotes the reaction [ABCC1 protein affects the export of 4-Nitroquinoline-1-oxide analog] | affects export|increases reaction | 15766272 |
| D005978 | Glutathione | Glutathione promotes the reaction [ABCC1 protein affects the transport of Bilirubin] | affects transport|increases reaction | 15245331 |
| D005978 | Glutathione | Glutathione results in increased stability of and results in decreased degradation of and affects the localization of ABCC1 protein mutant form | affects localization|decreases degradation|increases stability | 15581632 |
| D005978 | Glutathione | PAK 104P promotes the reaction [ABCC1 protein affects the export of Glutathione] | affects export|increases reaction | 15498506 |
| D005978 | Glutathione | Verapamil promotes the reaction [ABCC1 protein affects the export of Glutathione] | affects export|increases reaction | 15498506 |
| D005978 | Glutathione | Verapamil promotes the reaction [ABCC1 protein affects the transport of Glutathione] | affects transport|increases reaction | 11278867 |
| D005978 | Glutathione | ABCC1 protein affects the export of Glutathione | affects export | 15561710 |
| D005978 | Glutathione | ABCC1 protein promotes the reaction [Nitric Oxide results in increased secretion of Glutathione] | increases reaction|increases secretion | 16679408 |
| D005978 | Glutathione | buthionine sulfoximine ethyl ester promotes the reaction [ABCC1 protein results in increased export of Glutathione] | increases export|increases reaction | 12504668 |
| D005978 | Glutathione | ABCC1 protein affects the export of Glutathione | affects export | 15845416 |
| D019803 | Glutathione Disulfide | Glutathione Disulfide promotes the reaction [Leukotriene C4 analog binds to ABCC1 protein] | affects binding|increases reaction | 15628876 |
| D005905 | Glyburide | Glyburide results in decreased activity of ABCC1 protein | decreases activity | 15652236 |
| C075375 | grepafloxacin | ABCC1 protein affects the export of grepafloxacin | affects export | 15948026 |
| D006220 | Haloperidol | Haloperidol inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 15946544 |
| D006220 | Haloperidol | Haloperidol results in decreased expression of ABCC1 mRNA | decreases expression | 15946544 |
| D006493 | Heparin | Heparin affects the activity of ABCC1 protein | affects activity | 17352253 |
| D006493 | Heparin | Heparin affects the reaction [ABCC1 protein affects the transport of Doxorubicin] | affects reaction|affects transport | 17352253 |
| C013015 | hesperetin | hesperetin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 |
| C013015 | hesperetin | hesperetin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| C013015 | hesperetin | hesperetin promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 16156793 |
| C013038 | hydroxyhydroquinone | hydroxyhydroquinone results in increased expression of ABCC1 mRNA | increases expression | 17572062 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in increased expression of ABCC1 mRNA | increases expression | 11752103 |
| D007213 | Indomethacin | [Doxorubicin results in decreased expression of ABCC1 mRNA] which results in increased susceptibility to Indomethacin | decreases expression|increases response to substance | 16331495 |
| D007213 | Indomethacin | Indomethacin affects the reaction [ABCC1 protein results in increased transport of Valproic Acid] | affects reaction|increases transport | 15066675 |
| D007213 | Indomethacin | Indomethacin analog affects the activity of ABCC1 protein | affects activity | 15715484 |
| D007213 | Indomethacin | Indomethacin analog results in decreased activity of ABCC1 protein | decreases activity | 12142058 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [ABCC1 protein affects the export of 5-carboxyfluorescein diacetate] | affects export|decreases reaction | 16636798 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 17940500 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of ABCC1 protein | decreases activity | 17940500 15715484 15916776 15581599 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of ABCC1 mRNA | decreases expression | 18360721 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of ABCC1 protein | decreases activity | 15804283 |
| D007213 | Indomethacin | Indomethacin results in decreased activity of ABCC1 protein | decreases activity | 12893836 |
| D007213 | Indomethacin | [Indomethacin results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| C051890 | irinotecan | ABCC1 protein results in decreased susceptibility to irinotecan | decreases response to substance | 16815871 |
| C051890 | irinotecan | irinotecan analog results in decreased expression of ABCC1 mRNA | decreases expression | 18927307 |
| C051890 | irinotecan | [selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of ABCC1 | affects cotreatment|decreases expression | 15897249 |
| D007501 | Iron | ABCC1 protein promotes the reaction [Nitric Oxide results in increased secretion of Iron] | increases reaction|increases secretion | 16679408 |
| D007529 | Isoflavones | Isoflavones analog results in decreased activity of ABCC1 protein | decreases activity | 15916776 |
| D007538 | Isoniazid | Isoniazid results in increased expression of ABCC1 mRNA | increases expression | 11752103 |
| C006552 | kaempferol | kaempferol affects the activity of ABCC1 protein | affects activity | 15796199 |
| C006552 | kaempferol | kaempferol results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| D008070 | Lipopolysaccharides | Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of ABCC1 mRNA] | decreases reaction|increases expression | 15205389 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of ABCC1 mRNA | increases expression | 15205389 |
| D017997 | Leukotriene C4 | ABCC1 protein affects the transport of Leukotriene C4 | affects transport | 12516967 |
| D017997 | Leukotriene C4 | ABCC1 protein affects the transport of Leukotriene C4 | affects transport | 11278867 |
| D017997 | Leukotriene C4 | Adenosine Triphosphate promotes the reaction [ABCC1 protein affects the transport of Leukotriene C4] | affects transport|increases reaction | 15459206 15355964 |
| D017997 | Leukotriene C4 | Bilirubin inhibits the reaction [ABCC1 protein affects the transport of Leukotriene C4] | affects transport|decreases reaction | 15245331 |
| D017997 | Leukotriene C4 | estradiol-17 beta-glucuronide inhibits the reaction [ABCC1 protein affects the transport of Leukotriene C4] | affects transport|decreases reaction | 11278867 |
| D017997 | Leukotriene C4 | Glutathione Disulfide promotes the reaction [Leukotriene C4 analog binds to ABCC1 protein] | affects binding|increases reaction | 15628876 |
| D017997 | Leukotriene C4 | Leukotriene C4 analog binds to ABCC1 protein | affects binding | 15628876 |
| D017997 | Leukotriene C4 | ABCC1 protein affects the transport of Leukotriene C4 | affects transport | 12657726 |
| D017997 | Leukotriene C4 | [Adenosine Triphosphate binds to ABCC1 protein] inhibits the reaction [Leukotriene C4 binds to ABCC1 protein] | affects binding|decreases reaction | 15755910 |
| D047311 | Luteolin | Luteolin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| D015767 | Mefloquine | Mefloquine inhibits the reaction [ABCC1 protein affects the export of fluorexon] | affects export|decreases reaction | 16004972 |
| D015767 | Mefloquine | Mefloquine inhibits the reaction [ABCC1 protein affects the transport of S-(2,4-dinitrophenyl)glutathione] | affects transport|decreases reaction | 16004972 |
| D015767 | Mefloquine | Mefloquine inhibits the reaction [Prostaglandins E results in increased activity of ABCC1 protein] | decreases reaction|increases activity | 16004972 |
| D015767 | Mefloquine | Mefloquine inhibits the reaction [Quercetin results in increased activity of ABCC1 protein] | decreases reaction|increases activity | 16004972 |
| D015767 | Mefloquine | Mefloquine results in decreased activity of ABCC1 protein | decreases activity | 16004972 |
| D008558 | Melphalan | ABCC1 protein affects the export of Melphalan analog | affects export | 11115505 |
| D008627 | Mercuric Chloride | ABCC1 protein affects the export of and results in decreased susceptibility to Mercuric Chloride | affects export|decreases response to substance | 15590114 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of ABCC1 mRNA | increases expression | 15590114 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of ABCC1 protein | increases expression | 15590114 |
| D008627 | Mercuric Chloride | ABCC1 protein results in decreased susceptibility to Mercuric Chloride | decreases response to substance | 10685512 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of ABCC1 mRNA | increases expression | 15585369 |
| D008627 | Mercuric Chloride | Mercuric Chloride results in increased expression of and affects the localization of ABCC1 protein | affects localization|increases expression | 15585369 |
| D008627 | Mercuric Chloride | SB 203580 inhibits the reaction [Mercuric Chloride results in increased expression of and affects the localization of ABCC1 protein] | affects localization|decreases reaction|increases expression | 15585369 |
| D008627 | Mercuric Chloride | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Mercuric Chloride] | decreases reaction|decreases response to substance | 10685512 |
| D008628 | Mercury | ABCC1 protein affects the export of and results in decreased susceptibility to Mercury | affects export|decreases response to substance | 15590114 |
| D008628 | Mercury | Mercury results in increased expression of ABCC1 mRNA | increases expression | 15590114 |
| D008628 | Mercury | Mercury results in increased expression of ABCC1 protein | increases expression | 15590114 |
| D008727 | Methotrexate | ABCC1 protein affects the transport of Methotrexate | affects transport | 15718312 |
| D008731 | Methoxychlor | ABCC1 gene mutant form results in increased susceptibility to Methoxychlor | increases response to substance | 12765240 |
| D008731 | Methoxychlor | ABCC1 protein results in increased export of and results in decreased susceptibility to Methoxychlor | decreases response to substance|increases export | 12765240 |
| C066998 | methoxy-morpholinyl-doxorubicin | methoxy-morpholinyl-doxorubicin binds to and affects the folding of ABCC1 protein | affects binding|affects folding | 11278000 |
| D016685 | Mitomycin | ABCC1 protein results in decreased susceptibility to Mitomycin | decreases response to substance | 11778547 |
| C020300 | monomethylarsonic acid | monomethylarsonic acid results in increased expression of ABCC1 mRNA | increases expression | 16436460 |
| C020300 | monomethylarsonic acid | monomethylarsonic acid results in increased expression of ABCC1 protein | increases expression | 16436460 |
| C093875 | montelukast | ABCC1 gene SNP affects the susceptibility to montelukast | affects response to substance | 16293801 |
| C008548 | morin | morin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| C040015 | myricetin | myricetin inhibits the reaction [ABCC1 protein affects the export of and results in decreased susceptibility to Vincristine] | affects export|decreases reaction|decreases response to substance | 15896345 |
| C040015 | myricetin | myricetin inhibits the reaction [ABCC1 protein affects the export of Vincristine] | affects export|decreases reaction | 15896345 |
| C040015 | myricetin | myricetin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15896345 |
| C040015 | myricetin | myricetin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| D019810 | Sodium Azide | Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin]] | decreases reaction|decreases uptake | 10856430 |
| D019810 | Sodium Azide | Glucose inhibits the reaction [Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide]] | decreases reaction|decreases uptake | 10856430 |
| D019810 | Sodium Azide | Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin] | decreases reaction|decreases uptake | 10856430 |
| D019810 | Sodium Azide | Sodium Azide inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide] | decreases reaction|decreases uptake | 10856430 |
| D015058 | 1-Naphthylisothiocyanate | 1-Naphthylisothiocyanate results in increased expression of ABCC1 mRNA | increases expression | 15913567 |
| C005273 | naringenin | naringenin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 |
| C005273 | naringenin | naringenin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| C005273 | naringenin | naringenin promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 16156793 |
| D019888 | Nelfinavir | ABCC1 protein affects the transport of Nelfinavir | affects transport | 16041239 |
| C029938 | nickel sulfate | nickel sulfate results in increased expression of ABCC1 mRNA | increases expression | 16780908 |
| D009569 | Nitric Oxide | ABCC1 protein promotes the reaction [Nitric Oxide results in increased secretion of Glutathione] | increases reaction|increases secretion | 16679408 |
| D009569 | Nitric Oxide | ABCC1 protein promotes the reaction [Nitric Oxide results in increased secretion of Iron] | increases reaction|increases secretion | 16679408 |
| D015112 | 4-Nitroquinoline-1-oxide | ABCC1 protein affects the export of 4-Nitroquinoline-1-oxide analog | affects export | 15766272 |
| D015112 | 4-Nitroquinoline-1-oxide | Glutathione promotes the reaction [ABCC1 protein affects the export of 4-Nitroquinoline-1-oxide analog] | affects export|increases reaction | 15766272 |
| D034442 | N-substituted Glycines | N-substituted Glycines analog binds to and results in decreased activity of ABCC1 protein | affects binding|decreases activity | 15644429 |
| D053683 | Oncostatin M | Oncostatin M results in increased expression of ABCC1 mRNA | increases expression | 15654950 |
| D010126 | Ozone | [Ozone co-treated with Chlorine] results in decreased expression of ABCC1 mRNA | affects cotreatment|decreases expression | 18636392 |
| D010126 | Ozone | Ozone results in increased expression of ABCC1 mRNA | increases expression | 16330353 |
| D017239 | Paclitaxel | ABCC1 results in decreased susceptibility to Paclitaxel | decreases response to substance | 15548710 |
| C103821 | PAK 104P | PAK 104P inhibits the reaction [ABCC1 protein affects the export of Daunorubicin] | affects export|decreases reaction | 15498506 |
| C103821 | PAK 104P | PAK 104P promotes the reaction [ABCC1 protein affects the export of Glutathione] | affects export|increases reaction | 15498506 |
| D010862 | Pilocarpine | Pilocarpine affects the expression of ABCC1 mRNA | affects expression | 19055492 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of ABCC1 mRNA | decreases expression | 15465739 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of ABCC1 protein | decreases expression | 15465739 |
| D010936 | Plant Extracts | Plant Extracts results in increased expression of ABCC1 mRNA | increases expression | 18351577 |
| C422648 | pluronic block copolymer p85 | pluronic block copolymer p85 results in decreased folding of and results in decreased activity of ABCC1 protein | decreases activity|decreases folding | 15648254 |
| C025299 | polyphenols | polyphenols results in decreased expression of ABCC1 mRNA | decreases expression | 15465739 |
| C025299 | polyphenols | polyphenols results in decreased expression of ABCC1 protein | decreases expression | 15465739 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of ABCC1 mRNA | increases expression | 11752103 |
| D011339 | Probenecid | Probenecid affects the reaction [ABCC1 protein results in increased transport of Valproic Acid] | affects reaction|increases transport | 15066675 |
| D011339 | Probenecid | Probenecid results in decreased activity of ABCC1 protein | decreases activity | 15916776 15585369 15652236 |
| D011339 | Probenecid | Probenecid results in decreased activity of ABCC1 protein | decreases activity | 15804283 |
| D011339 | Probenecid | Probenecid results in decreased activity of ABCC1 protein | decreases activity | 12893836 |
| D011339 | Probenecid | [Probenecid results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| D011339 | Probenecid | Probenecid results in decreased activity of ABCC1 protein | decreases activity | 15456083 12387749 |
| D011353 | Prodigiosin | Prodigiosin results in increased expression of ABCC1 mRNA | increases expression | 15746575 |
| D011458 | Prostaglandins E | Mefloquine inhibits the reaction [Prostaglandins E results in increased activity of ABCC1 protein] | decreases reaction|increases activity | 16004972 |
| D011458 | Prostaglandins E | verlukast inhibits the reaction [Prostaglandins E results in increased activity of ABCC1 protein] | decreases reaction|increases activity | 16004972 |
| D011480 | Protease Inhibitors | ABCC1 protein affects the export of Protease Inhibitors | affects export | 15731742 |
| D011691 | Puromycin | Puromycin results in increased expression of ABCC1 mRNA | increases expression | 20018165 |
| D011794 | Quercetin | ABCC1 protein results in increased susceptibility to Quercetin | increases response to substance | 16156793 |
| D011794 | Quercetin | Mefloquine inhibits the reaction [Quercetin results in increased activity of ABCC1 protein] | decreases reaction|increases activity | 16004972 |
| D011794 | Quercetin | Quercetin affects the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | affects reaction|increases hydrolysis | 16156793 |
| D011794 | Quercetin | Quercetin inhibits the reaction [ABCC1 protein affects the export of S-(2,4-dinitrophenyl)glutathione] | affects export|decreases reaction | 15041478 |
| D011794 | Quercetin | Quercetin inhibits the reaction [ABCC1 protein results in increased export of fluorexon] | decreases reaction|increases export | 16156793 |
| D011794 | Quercetin | Quercetin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| D011794 | Quercetin | Quercetin results in decreased activity of ABCC1 protein | decreases activity | 15041478 15670588 |
| D011794 | Quercetin | Quercetin results in increased expression of ABCC1 mRNA | increases expression | 11836020 |
| D011794 | Quercetin | Quercetin results in increased expression of ABCC1 protein | increases expression | 11836020 |
| D011794 | Quercetin | verlukast inhibits the reaction [Quercetin results in increased activity of ABCC1 protein] | decreases reaction|increases activity | 16004972 |
| D011802 | Quinidine | Quinidine results in decreased activity of ABCC1 protein | decreases activity | 15666293 |
| D020849 | Raloxifene | [Raloxifene co-treated with ESR2 protein] results in decreased expression of ABCC1 mRNA | affects cotreatment|decreases expression | 19059307 |
| C059514 | resveratrol | ABCC1 protein results in decreased susceptibility to resveratrol | decreases response to substance | 16156793 |
| C059514 | resveratrol | resveratrol inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 |
| C059514 | resveratrol | resveratrol inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| C059514 | resveratrol | resveratrol promotes the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | increases hydrolysis|increases reaction | 16156793 |
| D012293 | Rifampin | Rifampin results in increased expression of ABCC1 mRNA | increases expression | 17191263 |
| C040014 | robinetin | robinetin inhibits the reaction [ABCC1 protein affects the export of fluorexon] | affects export|decreases reaction | 15670588 |
| C040014 | robinetin | robinetin results in decreased activity of ABCC1 protein | decreases activity | 15670588 |
| C005183 | robinin | robinin affects the activity of ABCC1 protein | affects activity | 15796199 |
| C087123 | romidepsin | ABCC1 protein binds to and affects the export of romidepsin | affects binding|affects export | 15634944 |
| C087123 | romidepsin | ABCC1 protein results in decreased susceptibility to romidepsin | decreases response to substance | 16049968 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | ABCC1 protein affects the export of S-(2,4-dinitrophenyl)glutathione | affects export | 15041478 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | ABCC1 protein affects the transport of S-(2,4-dinitrophenyl)glutathione | affects transport | 16004972 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione | increases export | 16156793 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | flavone inhibits the reaction [ABCC1 protein affects the export of S-(2,4-dinitrophenyl)glutathione] | affects export|decreases reaction | 15041478 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | hesperetin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | Mefloquine inhibits the reaction [ABCC1 protein affects the transport of S-(2,4-dinitrophenyl)glutathione] | affects transport|decreases reaction | 16004972 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | naringenin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | Quercetin inhibits the reaction [ABCC1 protein affects the export of S-(2,4-dinitrophenyl)glutathione] | affects export|decreases reaction | 15041478 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | Quercetin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | resveratrol inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | Silymarin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | taxifolin inhibits the reaction [ABCC1 protein affects the export of S-(2,4-dinitrophenyl)glutathione] | affects export|decreases reaction | 15041478 |
| C030190 | S-(2,4-dinitrophenyl)glutathione | verlukast inhibits the reaction [ABCC1 protein affects the transport of S-(2,4-dinitrophenyl)glutathione] | affects transport|decreases reaction | 16004972 |
| D019258 | Saquinavir | ABCC1 protein results in increased export of Saquinavir | increases export | 18535159 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Mercuric Chloride results in increased expression of and affects the localization of ABCC1 protein] | affects localization|decreases reaction|increases expression | 15585369 |
| C002979 | selenomethylselenocysteine | [selenomethylselenocysteine co-treated with irinotecan] results in decreased expression of ABCC1 | affects cotreatment|decreases expression | 15897249 |
| D012838 | Silymarin | Silymarin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 |
| D012838 | Silymarin | Silymarin inhibits the reaction [ABCC1 protein results in increased export of fluorexon] | decreases reaction|increases export | 16156793 |
| D012838 | Silymarin | Silymarin inhibits the reaction [ABCC1 protein results in increased export of S-(2,4-dinitrophenyl)glutathione] | decreases reaction|increases export | 16156793 |
| D012838 | Silymarin | Silymarin inhibits the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | decreases reaction|increases hydrolysis | 16156793 |
| C009277 | sodium arsenate | ABCC1 protein results in decreased susceptibility to sodium arsenate | decreases response to substance | 10685512 |
| C009277 | sodium arsenate | ABCC1 protein results in increased secretion of sodium arsenate | increases secretion | 10685512 |
| C009277 | sodium arsenate | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to sodium arsenate | affects expression|affects response to substance | 10348353 |
| C009277 | sodium arsenate | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to sodium arsenate] | decreases reaction|decreases response to substance | 10685512 |
| C017947 | sodium arsenite | ABCC1 protein results in decreased susceptibility to sodium arsenite | decreases response to substance | 8947035 |
| C017947 | sodium arsenite | ABCC1 protein affects the susceptibility to sodium arsenite | affects response to substance | 12731862 |
| C017947 | sodium arsenite | ABCC1 protein results in decreased susceptibility to sodium arsenite | decreases response to substance | 10685512 11278867 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of ABCC1 mRNA | increases expression | 20339138 |
| C017947 | sodium arsenite | ABCC1 protein affects the export of sodium arsenite | affects export | 15694464 |
| C017947 | sodium arsenite | IFNG protein promotes the reaction [sodium arsenite results in increased expression of ABCC1 protein] | increases expression|increases reaction | 17003472 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of ABCC1 mRNA | increases expression | 17003472 15694464 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of ABCC1 protein | increases expression | 17003472 15694464 |
| C017947 | sodium arsenite | TGFB1 protein inhibits the reaction [sodium arsenite results in increased expression of ABCC1 protein] | decreases reaction|increases expression | 17003472 |
| C017947 | sodium arsenite | ABCC1 protein results in decreased susceptibility to sodium arsenite | decreases response to substance | 11455017 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of ABCC1 mRNA | increases expression | 11455017 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of ABCC1 protein | increases expression | 11455017 |
| C017947 | sodium arsenite | ABCC1 protein results in increased export of sodium arsenite | increases export | 17003472 |
| D012965 | Sodium Chloride | [Acetaminophen co-treated with Sodium Chloride] results in increased expression of ABCC1 mRNA | affects cotreatment|increases expression | 17934960 |
| D013024 | Soybean Oil | Soybean Oil affects the expression of ABCC1 mRNA | affects expression | 15770074 |
| D013442 | Sulfinpyrazone | Sulfinpyrazone results in decreased activity of ABCC1 protein | decreases activity | 15044619 |
| D013442 | Sulfinpyrazone | Sulfinpyrazone results in decreased activity of ABCC1 protein | decreases activity | 12893836 |
| D013442 | Sulfinpyrazone | [Sulfinpyrazone results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| D013467 | Sulindac | Acetylcysteine inhibits the reaction [Sulindac results in increased expression of ABCC1 protein] | decreases reaction|increases expression | 11820781 |
| D013467 | Sulindac | Sulindac results in increased expression of ABCC1 protein | increases expression | 11820781 |
| D013629 | Tamoxifen | [Tamoxifen co-treated with ESR2 protein] results in decreased expression of ABCC1 mRNA | affects cotreatment|decreases expression | 19059307 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of ABCC1 mRNA | affects expression | 17555576 |
| C080625 | taxane | taxane analog affects the activity of ABCC1 protein | affects activity | 15771464 |
| C003377 | taxifolin | taxifolin inhibits the reaction [ABCC1 protein affects the export of S-(2,4-dinitrophenyl)glutathione] | affects export|decreases reaction | 15041478 |
| C003377 | taxifolin | taxifolin results in decreased activity of ABCC1 protein | decreases activity | 15041478 |
| D017256 | Technetium Tc 99m Sestamibi | ABCC1 protein affects the transport of Technetium Tc 99m Sestamibi analog | affects transport | 15989470 |
| C078700 | technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane | ABCC1 protein affects the transport of technetium Tc 99m 1,2-bis(bis(2-ethoxyethyl)phosphino)ethane analog | affects transport | 15989470 |
| D013739 | Testosterone | ABCC1 protein affects the glucuronidation of Testosterone | affects glucuronidation | 14742140 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of ABCC1 mRNA | affects cotreatment|increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ABCC1 mRNA | increases expression | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of ABCC1 mRNA | increases expression | 11752103 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in decreased expression of ABCC1 protein | decreases expression | 15517594 |
| D013852 | Thiotepa | ABCC1 protein results in decreased susceptibility to Thiotepa | decreases response to substance | 11778547 |
| D024505 | Tocopherols | Tocopherols inhibits the reaction [ABCC1 protein affects the export of Etoposide] | affects export|decreases reaction | 15617835 |
| D024505 | Tocopherols | Tocopherols results in decreased activity of ABCC1 protein | decreases activity | 15617835 |
| D014050 | Toluene | Toluene affects the expression of ABCC1 mRNA | affects expression | 18653662 |
| C052920 | trimethylarsine oxide | trimethylarsine oxide results in increased expression of ABCC1 mRNA | increases expression | 16436460 |
| C052920 | trimethylarsine oxide | trimethylarsine oxide results in increased expression of ABCC1 protein | increases expression | 16436460 |
| D014415 | Tunicamycin | Tunicamycin results in increased expression of ABCC1 mRNA | increases expression | 17127020 |
| C113580 | U 0126 | U 0126 results in decreased expression of ABCC1 mRNA | decreases expression | 15526378 |
| C113580 | U 0126 | U 0126 results in decreased expression of ABCC1 protein | decreases expression | 15526378 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid affects the expression of ABCC1 mRNA | affects expression | 15452192 |
| D014635 | Valproic Acid | ABCC1 protein results in increased transport of Valproic Acid | increases transport | 15066675 |
| D014635 | Valproic Acid | ABCC1 protein results in increased transport of Valproic Acid | increases transport | 15066675 |
| D014635 | Valproic Acid | Indomethacin affects the reaction [ABCC1 protein results in increased transport of Valproic Acid] | affects reaction|increases transport | 15066675 |
| D014635 | Valproic Acid | Probenecid affects the reaction [ABCC1 protein results in increased transport of Valproic Acid] | affects reaction|increases transport | 15066675 |
| D014638 | Vanadates | Vanadates inhibits the reaction [ABCC1 protein results in increased hydrolysis of Adenosine Triphosphate] | decreases reaction|increases hydrolysis | 10856430 |
| D014638 | Vanadates | Vanadates promotes the reaction [8-azidoadenosine 5'-triphosphate binds to ABCC1 protein] | affects binding|increases reaction | 12069597 |
| C047426 | venlafaxine | venlafaxine results in increased expression of ABCC1 mRNA | increases expression | 17191263 |
| D014700 | Verapamil | Verapamil results in decreased activity of ABCC1 protein | decreases activity | 15666293 |
| D014700 | Verapamil | Verapamil inhibits the reaction [ABCC1 protein affects the export of 5-carboxyfluorescein diacetate] | affects export|decreases reaction | 16636798 |
| D014700 | Verapamil | Verapamil inhibits the reaction [ABCC1 protein affects the export of Daunorubicin] | affects export|decreases reaction | 15498506 |
| D014700 | Verapamil | Verapamil promotes the reaction [ABCC1 protein affects the export of Glutathione] | affects export|increases reaction | 15498506 |
| D014700 | Verapamil | Verapamil promotes the reaction [ABCC1 protein affects the transport of Glutathione] | affects transport|increases reaction | 11278867 |
| D014700 | Verapamil | Verapamil results in decreased activity of ABCC1 protein | decreases activity | 15044619 15451006 |
| D014700 | Verapamil | Verapamil inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 10856430 |
| D014700 | Verapamil | Verapamil inhibits the reaction [ABCC1 protein results in decreased uptake of Daunorubicin] | decreases reaction|decreases uptake | 10856430 |
| D014700 | Verapamil | Verapamil inhibits the reaction [ABCC1 protein results in decreased uptake of Etoposide] | decreases reaction|decreases uptake | 10856430 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein affects the export of fluorexon] | affects export|decreases reaction | 16004972 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein affects the transport of Bilirubin] | affects transport|decreases reaction | 15245331 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein affects the transport of S-(2,4-dinitrophenyl)glutathione] | affects transport|decreases reaction | 16004972 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Antimony Potassium Tartrate] | decreases reaction|decreases response to substance | 10025956 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to arsenic trioxide] | decreases reaction|decreases response to substance | 11331074 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Doxorubicin] | decreases reaction|decreases response to substance | 15180633 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Etoposide] | decreases reaction|decreases response to substance | 16156793 15180633 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Mercuric Chloride] | decreases reaction|decreases response to substance | 10685512 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to sodium arsenate] | decreases reaction|decreases response to substance | 10685512 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15180633 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in increased export of fluorexon] | decreases reaction|increases export | 16156793 |
| C059141 | verlukast | verlukast inhibits the reaction [ABCC1 protein results in increased secretion of Antimony Potassium Tartrate] | decreases reaction|increases secretion | 10025956 |
| C059141 | verlukast | verlukast inhibits the reaction [Prostaglandins E results in increased activity of ABCC1 protein] | decreases reaction|increases activity | 16004972 |
| C059141 | verlukast | verlukast inhibits the reaction [Quercetin results in increased activity of ABCC1 protein] | decreases reaction|increases activity | 16004972 |
| C059141 | verlukast | verlukast results in decreased activity of ABCC1 protein | decreases activity | 15041478 16004972 16049968 15451006 15180633 15916776 |
| C059141 | verlukast | verlukast results in decreased activity of ABCC1 protein | decreases activity | 15694464 15804283 |
| C059141 | verlukast | verlukast results in decreased activity of ABCC1 protein | decreases activity | 12893836 |
| C059141 | verlukast | [verlukast results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| C059141 | verlukast | verlukast results in decreased activity of ABCC1 protein | decreases activity | 15744065 15282097 15590114 12490585 11455017 |
| D014747 | Vinblastine | ABCC1 protein results in decreased susceptibility to Vinblastine | decreases response to substance | 16156793 |
| D014747 | Vinblastine | ABCC1 protein results in decreased susceptibility to Vinblastine | decreases response to substance | 11455017 |
| D014750 | Vincristine | ABCC1 protein results in decreased susceptibility to Vincristine | decreases response to substance | 12067707 |
| D014750 | Vincristine | ABCC1 protein results in decreased susceptibility to Vincristine | decreases response to substance | 12516967 |
| D014750 | Vincristine | ABCC1 protein affects the export of and results in decreased susceptibility to Vincristine | affects export|decreases response to substance | 15896345 |
| D014750 | Vincristine | ABCC1 protein affects the export of Vincristine | affects export | 15896345 |
| D014750 | Vincristine | ABCC1 protein affects the susceptibility to Vincristine | affects response to substance | 12731862 |
| D014750 | Vincristine | ABCC1 protein affects the transport of Vincristine | affects transport | 15581632 10685512 |
| D014750 | Vincristine | ABCC1 protein mutant form affects the transport of Vincristine | affects transport | 15581632 |
| D014750 | Vincristine | ABCC1 protein results in decreased susceptibility to Vincristine | decreases response to substance | 10900222 15180633 11278867 15044619 11778547 16042792 15896345 12067707 |
| D014750 | Vincristine | Buthionine Sulfoximine inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15180633 |
| D014750 | Vincristine | Doxorubicin inhibits the reaction [ABCC1 protein affects the transport of Vincristine] | affects transport|decreases reaction | 10685512 |
| D014750 | Vincristine | GSTP1 protein promotes the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases response to substance|increases reaction | 10900222 |
| D014750 | Vincristine | [MYCN protein affects the expression of ABCC1 mRNA] which affects the susceptibility to Vincristine | affects expression|affects response to substance | 10348353 |
| D014750 | Vincristine | myricetin inhibits the reaction [ABCC1 protein affects the export of and results in decreased susceptibility to Vincristine] | affects export|decreases reaction|decreases response to substance | 15896345 |
| D014750 | Vincristine | myricetin inhibits the reaction [ABCC1 protein affects the export of Vincristine] | affects export|decreases reaction | 15896345 |
| D014750 | Vincristine | myricetin inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15896345 |
| D014750 | Vincristine | verlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15180633 |
| D014750 | Vincristine | Vincristine inhibits the reaction [ABCC1 protein affects the transport of fluorexon] | affects transport|decreases reaction | 10685512 |
| D014750 | Vincristine | zafirlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15180633 |
| D014750 | Vincristine | ABCC1 protein results in decreased susceptibility to Vincristine | decreases response to substance | 12657726 |
| D014750 | Vincristine | [Genistein results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| D014750 | Vincristine | [Indomethacin results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| D014750 | Vincristine | [Probenecid results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| D014750 | Vincristine | [Sulfinpyrazone results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| D014750 | Vincristine | [verlukast results in decreased activity of ABCC1 protein] which results in increased uptake of Vincristine | decreases activity|increases uptake | 12893836 |
| C062735 | zafirlukast | zafirlukast inhibits the reaction [ABCC1 protein results in decreased susceptibility to Vincristine] | decreases reaction|decreases response to substance | 15180633 |
| C063449 | zileuton | ABCC1 gene SNP affects the susceptibility to zileuton | affects response to substance | 19214143 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000008 | Abdominal Neoplasms | Sulindac | 9.01 | 14745880 | |
| MESH:D000008 | Abdominal Neoplasms | Tamoxifen | 9.01 | 14745880 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Disulfiram | 10.93 | 17676605 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Methotrexate | 10.93 | 12039119 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 10.93 | 14514962 15322242 11752688 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Valproic Acid | 10.93 | 8875741 | |
| MESH:D000015 | Abnormalities, Multiple | Valproic Acid | 2.83 | 19490988 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 2.38 | 18287403 | |
| MESH:D000152 | Acne Vulgaris | Ethinyl Estradiol | 8.11 | 17505938 | |
| MESH:D000152 | Acne Vulgaris | zileuton | 8.11 | 20436887 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Disulfiram | 4.39 | 9207937 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.31 | 17694057 | |
| MESH:D058186 | Acute Kidney Injury | Cisplatin | 15.48 | 17670903 15814532 12690470 | |
| MESH:D058186 | Acute Kidney Injury | Folic Acid | 15.48 | 16316344 17003819 16595132 | |
| MESH:D058186 | Acute Kidney Injury | Mercuric Chloride | 15.48 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 15.48 | 16538975 | |
| MESH:D058186 | Acute Kidney Injury | Sulindac | 15.48 | 7897758 | |
| MESH:D055371 | Acute Lung Injury | Chlorine | 16.92 | 20601635 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 16.92 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | nickel sulfate | 16.92 | 19131640 12718980 11954676 16100012 | |
| MESH:D055371 | Acute Lung Injury | verlukast | 16.92 | 17118201 | |
| MESH:D055371 | Acute Lung Injury | zileuton | 16.92 | 17118201 | |
| MESH:D000230 | Adenocarcinoma | arsenic trioxide | 24.06 | 19825857 11798837 | |
| MESH:D000230 | Adenocarcinoma | Cisplatin | 24.06 | 17638652 11798837 | |
| MESH:D000230 | Adenocarcinoma | daidzein | 24.06 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 24.06 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 24.06 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Ethinyl Estradiol | 24.06 | 14692618 | |
| MESH:D000230 | Adenocarcinoma | Fluorouracil | 24.06 | 17638652 | |
| MESH:D000230 | Adenocarcinoma | Genistein | 24.06 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 24.06 | 16537180 | |
| MESH:D000230 | Adenocarcinoma | Sulindac | 24.06 | 11910360 | |
| MESH:D000230 | Adenocarcinoma | Vincristine | 24.06 | 19825857 | |
| MESH:D000236 | Adenoma | 2-Acetylaminofluorene | 18.79 | 10737359 | |
| MESH:D000236 | Adenoma | 4,4'-diaminodiphenylmethane | 18.79 | 3712494 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 18.79 | 19389873 | |
| MESH:D000236 | Adenoma | Folic Acid | 18.79 | 16963246 | |
| MESH:D000236 | Adenoma | Indomethacin | 18.79 | 11497255 | |
| MESH:D000236 | Adenoma | resveratrol | 18.79 | 15688382 | |
| MESH:D000236 | Adenoma | Sulindac | 18.79 | 10223192 | |
| MESH:D002759 | Adenoma, Bile Duct | 2-Acetylaminofluorene | 4.79 | 6705139 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 2.20 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Sulindac | 3.53 | 15623613 11874996 16460482 19003578 12394442 17611924 11535846 | |
| MESH:D000310 | Adrenal Gland Neoplasms | sodium arsenite | 3.49 | 15276417 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 9.78 | 17306315 | |
| MESH:D018246 | Adrenocortical Adenoma | sodium arsenite | 9.78 | 16712894 17306315 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 7.66 | 21441931 | |
| MESH:D000419 | Albuminuria | Raloxifene | 7.66 | 17308373 17451421 | |
| MESH:D000437 | Alcoholism | Disulfiram | 3.98 | 10841824 17079463 18968458 | |
| MESH:D019973 | Alcohol-Related Disorders | Curcumin | 3.87 | 17887948 | |
| OMIM:607154 | ALLERGIC RHINITIS | zafirlukast | 4.34 | 16527031 | |
| MESH:D000505 | Alopecia | Isoflavones | 3.71 | 17569567 | |
| MESH:D019896 | alpha 1-Antitrypsin Deficiency | Iron | 4.46 | 16640825 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 4.16 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | bis(4-hydroxycinnamoyl)methane | 19.51 | 19090986 | |
| MESH:D000544 | Alzheimer Disease | Curcumin | 19.51 | 15590663 | |
| MESH:D000544 | Alzheimer Disease | Folic Acid | 19.51 | 17116317 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 19.51 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Iron | 19.51 | 16640825 16563566 | |
| MESH:D000544 | Alzheimer Disease | Nitric Oxide | 19.51 | 17556102 | |
| MESH:D000544 | Alzheimer Disease | Ozone | 19.51 | 15513908 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 19.51 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | Raloxifene | 19.51 | 15800139 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 19.51 | 16162502 16183991 | |
| MESH:D000550 | Amblyopia | Valproic Acid | 4.02 | 17688650 | |
| MESH:D000690 | Amyotrophic Lateral Sclerosis | 4-hydroxy-2-nonenal | 3.23 | 10965797 | |
| MESH:D000740 | Anemia | Fluorouracil | 8.72 | 16511603 15504547 17963324 | |
| MESH:D000740 | Anemia | Iron | 8.72 | 16566752 16434484 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 8.72 | 11748828 | |
| MESH:D000743 | Anemia, Hemolytic | Quercetin | 3.14 | 17084956 | |
| MESH:D018798 | Anemia, Iron-Deficiency | Iron | 3.57 | 17163184 17162259 17147795 16569441 17375513 | |
| MESH:D000756 | Anemia, Sideroblastic | Iron | 3.71 | 16910769 | |
| MESH:D000799 | Angioedema | Acetaminophen | 8.18 | 10982225 | |
| MESH:D000799 | Angioedema | montelukast | 8.18 | 10982225 | |
| MESH:D000987 | Antisocial Personality Disorder | Testosterone | 4.64 | 7506515 | |
| MESH:D001008 | Anxiety Disorders | Valproic Acid | 2.57 | 17497229 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 3.70 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 3.70 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Iron | 6.19 | 16604332 | |
| MESH:D001145 | Arrhythmias, Cardiac | Quinidine | 6.19 | 18057881 18724381 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.38 | 12569548 18414634 16251483 16835338 | |
| MESH:D001161 | Arteriosclerosis | Cyclophosphamide | 6.32 | 15014928 | |
| MESH:D001161 | Arteriosclerosis | Ethinyl Estradiol | 6.32 | 11256880 | |
| MESH:D018771 | Arthralgia | Indomethacin | 3.96 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 10.37 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Ethinyl Estradiol | 10.37 | 15885639 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 10.37 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 10.37 | 17115116 | |
| MESH:D001172 | Arthritis, Rheumatoid | Curcumin | 6.45 | 16807698 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 6.45 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | Methotrexate | 6.45 | 17286800 | |
| MESH:D001172 | Arthritis, Rheumatoid | Ozone | 6.45 | 15570426 | |
| MESH:D001249 | Asthma | montelukast | 6.66 | 17895592 20332717 16293801 19667530 10852428 19681236 | |
| MESH:D001249 | Asthma | Ozone | 6.66 | 16373670 17854713 | |
| MESH:D001249 | Asthma | zafirlukast | 6.66 | 1673495 9027267 9377612 10929920 14609035 10064661 11991558 20332717 11393122 19667530 12604023 11596838 12583521 10359889 11885876 10386485 9825082 15170009 15136378 10967152 10934090 10439636 19681236 10817796 9690572 11061985 10780761 12114351 9412547 12113382 18489783 9620946 11070746 8222486 15572850 8087328 9949315 8162986 9620945 11570617 12742009 9847434 10852428 11694805 12189465 9196086 9701106 10027429 12095178 | |
| MESH:D001249 | Asthma | zileuton | 6.66 | 20332717 17944539 10764316 19214143 10181070 9620945 8598621 | |
| MESH:D055963 | Asthma, Aspirin-Induced | montelukast | 7.37 | 19667532 | |
| MESH:D055963 | Asthma, Aspirin-Induced | zafirlukast | 7.37 | 19667532 | |
| MESH:D001250 | Asthma, Exercise-Induced | montelukast | 12.70 | 19667531 10984370 | |
| MESH:D001250 | Asthma, Exercise-Induced | zafirlukast | 12.70 | 1554195 8389103 11953129 10984370 19667531 | |
| MESH:D001250 | Asthma, Exercise-Induced | zileuton | 12.70 | 10984370 | |
| MESH:D001260 | Ataxia Telangiectasia | Iron | 9.16 | 15336622 | |
| MESH:D001260 | Ataxia Telangiectasia | Quercetin | 9.16 | 15336622 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 11.55 | 12928151 19371607 | |
| MESH:D050197 | Atherosclerosis | Cadmium | 11.55 | 15687053 | |
| MESH:D050197 | Atherosclerosis | Curcumin | 11.55 | 18704882 | |
| MESH:D050197 | Atherosclerosis | Iron | 11.55 | 16632123 16640825 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 11.55 | 17967414 16873680 | |
| MESH:D001321 | Autistic Disorder | Acetaminophen | 4.39 | 18445737 | |
| MESH:D001321 | Autistic Disorder | Folic Acid | 4.39 | 21388746 | |
| MESH:D001321 | Autistic Disorder | Glutathione | 4.39 | 16917939 19267885 19056591 18929414 | |
| MESH:D001321 | Autistic Disorder | Glutathione Disulfide | 4.39 | 19056591 | |
| MESH:D001321 | Autistic Disorder | Haloperidol | 4.39 | 18080171 19368416 | |
| MESH:D001321 | Autistic Disorder | Iron | 4.39 | 17352947 | |
| MESH:D001321 | Autistic Disorder | Mercury | 4.39 | 17497416 | |
| MESH:D001321 | Autistic Disorder | Valproic Acid | 4.39 | 19460635 17157402 18775368 18316065 18985861 17507914 18177632 20603192 18558336 15238991 18396377 18940202 16609825 17688650 19232924 | |
| MESH:D001327 | Autoimmune Diseases | Curcumin | 11.46 | 19761891 | |
| MESH:D001327 | Autoimmune Diseases | Mercury | 11.46 | 16634805 | |
| MESH:D001327 | Autoimmune Diseases | Quercetin | 11.46 | 19761891 | |
| MESH:D001424 | Bacterial Infections | Iron | 4.01 | 16640825 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 3.81 | 10684365 | |
| MESH:D001528 | Behcet Syndrome | Colchicine | 4.94 | 15870978 | |
| MESH:D001660 | Biliary Tract Diseases | 4,4'-diaminodiphenylmethane | 3.80 | 11289319 1440618 | |
| MESH:D001714 | Bipolar Disorder | Valproic Acid | 2.31 | 20046352 17594078 | |
| MESH:D001778 | Blood Coagulation Disorders | arsenic trioxide | 5.34 | 16206674 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 5.34 | 12125929 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.58 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 5.01 | 15746008 | |
| MESH:D001848 | Bone Diseases, Developmental | Valproic Acid | 5.01 | 8888407 | |
| MESH:D019046 | Bone Marrow Neoplasms | Cisplatin | 19.53 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Dactinomycin | 19.53 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 19.53 | 14601052 | |
| MESH:D019046 | Bone Marrow Neoplasms | Etoposide | 19.53 | 14601052 | |
| MESH:D001859 | Bone Neoplasms | Paclitaxel | 3.45 | 15867366 | |
| MESH:D001913 | Bowen's Disease | Sulindac | 4.15 | 11207687 | |
| MESH:D001929 | Brain Edema | Indomethacin | 8.88 | 11481608 | |
| MESH:D001929 | Brain Edema | zileuton | 8.88 | 19309543 | |
| MESH:D001930 | Brain Injuries | Raloxifene | 3.31 | 16580743 | |
| MESH:D002545 | Brain Ischemia | Curcumin | 14.68 | 16770732 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 14.68 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 14.68 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 14.68 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Curcumin | 5.43 | 17596214 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 5.43 | 17150277 | |
| MESH:D001943 | Breast Neoplasms | Apigenin | 28.54 | 17132221 16541309 | |
| MESH:D001943 | Breast Neoplasms | Cacodylic Acid | 28.54 | 17474063 | |
| MESH:D001943 | Breast Neoplasms | Cisplatin | 28.54 | 19526202 18382427 | |
| MESH:D001943 | Breast Neoplasms | Curcumin | 28.54 | 19250217 18462866 16243823 18593918 | |
| MESH:D001943 | Breast Neoplasms | Cyclophosphamide | 28.54 | 15136595 11325840 16978400 18323546 12006526 18234424 17020986 17388661 15093573 | |
| MESH:D001943 | Breast Neoplasms | Disulfiram | 28.54 | 17026967 | |
| MESH:D001943 | Breast Neoplasms | docetaxel | 28.54 | 18628466 17369602 15692762 15567936 16264153 16495393 19526202 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 28.54 | 18695136 15567936 18234424 17426702 18628466 18382427 16264153 15136595 16096432 11325840 15939500 17983394 19526202 15993339 15994142 16935488 15634643 17369602 15692762 16595493 16322301 16826403 16115903 15668708 | |
| MESH:D001943 | Breast Neoplasms | Epirubicin | 28.54 | 15093573 18511948 12006526 17388661 16642371 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 28.54 | 17289903 12948864 17261762 16675129 19861407 14630087 17018787 18497071 | |
| MESH:D001943 | Breast Neoplasms | Etoposide | 28.54 | 16322251 | |
| MESH:D001943 | Breast Neoplasms | Fluorouracil | 28.54 | 16110121 18608205 19217205 16595493 18357371 16557594 15136595 | |
| MESH:D001943 | Breast Neoplasms | Folic Acid | 28.54 | 16777985 | |
| MESH:D001943 | Breast Neoplasms | Genistein | 28.54 | 16873071 16541309 17200150 | |
| MESH:D001943 | Breast Neoplasms | indole-3-carbinol | 28.54 | 16082211 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 28.54 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | kaempferol | 28.54 | 16756079 | |
| MESH:D001943 | Breast Neoplasms | Methotrexate | 28.54 | 16978400 | |
| MESH:D001943 | Breast Neoplasms | Nitric Oxide | 28.54 | 15631943 | |
| MESH:D001943 | Breast Neoplasms | Paclitaxel | 28.54 | 15136595 18234424 16244791 18223236 16273361 16115903 18323546 11325840 | |
| MESH:D001943 | Breast Neoplasms | Quercetin | 28.54 | 18628248 | |
| MESH:D001943 | Breast Neoplasms | Raloxifene | 28.54 | 17261762 17440819 16837676 17049068 17952589 17893378 17242785 15758505 15775269 15572757 17595753 16912660 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 28.54 | 17534123 17651959 16393696 | |
| MESH:D001943 | Breast Neoplasms | selenomethylselenocysteine | 28.54 | 18855134 | |
| MESH:D001943 | Breast Neoplasms | Sulindac | 28.54 | 16642371 | |
| MESH:D001943 | Breast Neoplasms | Tamoxifen | 28.54 | 19115204 18629630 19288272 19142967 19103187 19189210 17261762 19189212 19200415 19084267 17440819 16202921 19410462 18855134 16873071 19011961 21152245 19221464 20390343 17893378 19487384 18815881 15668708 18997820 20859285 16273361 21138602 19059307 15565566 17242785 17049068 20005174 20544844 16818667 19244106 19289846 19066611 18984771 20065188 18425577 20135344 11161223 19155303 18821012 18351453 | |
| MESH:D001943 | Breast Neoplasms | Testosterone | 28.54 | 17261762 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 28.54 | 20435547 | |
| MESH:D001982 | Bronchial Diseases | zafirlukast | 5.52 | 11994701 | |
| MESH:D016535 | Bronchial Hyperreactivity | Leukotriene C4 | 12.11 | 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | Ozone | 12.11 | 15516495 17626835 16777450 19059883 14754758 18417511 18315731 | |
| MESH:D016535 | Bronchial Hyperreactivity | verlukast | 12.11 | 12654629 | |
| MESH:D016535 | Bronchial Hyperreactivity | zileuton | 12.11 | 12388339 12654629 12794006 | |
| MESH:D001986 | Bronchial Spasm | Chlorpheniramine | 8.99 | 11432448 | |
| MESH:D001986 | Bronchial Spasm | verlukast | 8.99 | 11432448 | |
| MESH:D001991 | Bronchitis | Antimony | 4.92 | 8768112 | |
| MESH:D002051 | Burkitt Lymphoma | arsenic trioxide | 3.20 | 11589617 | |
| MESH:D002056 | Burns | Indomethacin | 3.54 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 4.13 | 9625245 | |
| MESH:D002100 | Cachexia | Indomethacin | 8.45 | 15625704 16537180 11239499 15141370 | |
| MESH:D002100 | Cachexia | Ozone | 8.45 | 16183385 | |
| MESH:D002105 | Cadmium Poisoning | Quercetin | 4.33 | 16962696 | |
| MESH:D002177 | Candidiasis | Disulfiram | 4.66 | 15325261 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 9.24 | 16111702 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | zafirlukast | 9.24 | 15170009 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 2.63 | 16011737 16097048 16124888 10355542 18705752 16050911 15673190 16192424 15700767 3786805 15721981 16227642 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 8.35 | 16051944 | |
| MESH:D002276 | Carcinoid Tumor | Fluorouracil | 8.35 | 16051944 | |
| MESH:D002277 | Carcinoma | Curcumin | 11.74 | 18593918 | |
| MESH:D002277 | Carcinoma | Disulfiram | 11.74 | 17026967 | |
| MESH:D002277 | Carcinoma | Fluorouracil | 11.74 | 17121937 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 11.74 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.77 | 17687452 15504454 | |
| MESH:D018270 | Carcinoma, Ductal, Breast | Tamoxifen | 3.33 | 19066611 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2,6-dinitrotoluene | 46.03 | 16705839 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 2-Acetylaminofluorene | 46.03 | 3581430 17761372 10737359 3084413 6705139 | |
| MESH:D006528 | Carcinoma, Hepatocellular | 4,4'-diaminodiphenylmethane | 46.03 | 7296757 3581430 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Acetaminophen | 46.03 | 3084413 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 46.03 | 17306315 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | arsenic trioxide | 46.03 | 15073043 16217749 11135700 14691202 15553829 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 46.03 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cisplatin | 46.03 | 17982673 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Cyclophosphamide | 46.03 | 19701751 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 46.03 | 16234567 16023760 18059187 17876044 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 46.03 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estrogens | 46.03 | 15341023 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Fluorouracil | 46.03 | 16799960 17971768 18930000 17088986 16332177 17045692 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Genistein | 46.03 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 46.03 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | morin | 46.03 | 19539802 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Paclitaxel | 46.03 | 16313753 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 46.03 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Quercetin | 46.03 | 19519916 12508355 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 46.03 | 19321006 16227395 | |
| MESH:D006528 | Carcinoma, Hepatocellular | sodium arsenite | 46.03 | 15276417 17306315 16507464 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Tamoxifen | 46.03 | 16924424 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Cyclophosphamide | 12.28 | 16152834 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 12.28 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 12.28 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 4.16 | 14736730 11352223 18791128 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Cisplatin | 7.64 | 16685392 12023789 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Curcumin | 7.64 | 18414057 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | Disulfiram | 7.64 | 17026967 | |
| MESH:D002289 | Carcinoma, Non-Small-Cell Lung | docetaxel | 7.64 | 11894018 | |
| MESH:D021441 | Carcinoma, Pancreatic Ductal | Quercetin | 3.78 | 17234771 | |
| MESH:D002291 | Carcinoma, Papillary | arsenic trioxide | 3.66 | 19014326 | |
| MESH:D002292 | Carcinoma, Renal Cell | 4,4'-diaminodiphenylmethane | 22.64 | 7296757 | |
| MESH:D002292 | Carcinoma, Renal Cell | Cyclophosphamide | 22.64 | 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 22.64 | 1485588 16201981 | |
| MESH:D002292 | Carcinoma, Renal Cell | ferric nitrilotriacetate | 22.64 | 8340253 | |
| MESH:D002292 | Carcinoma, Renal Cell | Fluorouracil | 22.64 | 18695887 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 22.64 | 17341418 | |
| MESH:D002292 | Carcinoma, Renal Cell | Vinblastine | 22.64 | 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Vincristine | 22.64 | 16201981 | |
| MESH:D018288 | Carcinoma, Small Cell | arsenic trioxide | 3.03 | 12490120 | |
| MESH:D002294 | Carcinoma, Squamous Cell | 4-Nitroquinoline-1-oxide | 31.28 | 16543248 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Acetylcysteine | 31.28 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 31.28 | 15504454 18922899 17687452 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Cisplatin | 31.28 | 6189445 17066447 18337622 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Curcumin | 31.28 | 18462866 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 31.28 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Fluorouracil | 31.28 | 16757204 17066447 16280240 18986760 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Glutathione | 31.28 | 17015178 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 31.28 | 12636206 15482327 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 31.28 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | sodium arsenite | 31.28 | 18572023 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 31.28 | 18922899 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Vincristine | 31.28 | 6189445 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 13.99 | 18640142 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Raloxifene | 13.99 | 17572228 | |
| MESH:D002295 | Carcinoma, Transitional Cell | romidepsin | 13.99 | 17230511 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Tamoxifen | 13.99 | 17572228 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 6.71 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Quercetin | 6.71 | 19794523 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 6.71 | 18670907 16120746 18850075 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 5.14 | 16242529 16731534 15505089 16651473 16109756 17329180 17924179 17519947 16952015 15476868 17974986 17308081 17928571 17007740 16278810 16612575 15792986 16364871 16269455 17131338 17351982 16455267 15811867 17382496 18627295 | |
| MESH:D009202 | Cardiomyopathies | Iron | 5.14 | 16640825 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Antimony | 8.47 | 10334427 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 8.47 | 17334414 16243910 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Iron | 8.47 | 16604332 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Mercury | 8.47 | 10334427 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 23.80 | 19152805 15738583 17938729 | |
| MESH:D002318 | Cardiovascular Diseases | daidzein | 23.80 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Folic Acid | 23.80 | 16755160 | |
| MESH:D002318 | Cardiovascular Diseases | Genistein | 23.80 | 16332659 | |
| MESH:D002318 | Cardiovascular Diseases | Isoflavones | 23.80 | 17689850 | |
| MESH:D002318 | Cardiovascular Diseases | kaempferol | 23.80 | 16756079 | |
| MESH:D002318 | Cardiovascular Diseases | Raloxifene | 23.80 | 15775269 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 23.80 | 15458977 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.25 | 16973168 18022660 | |
| MESH:D002375 | Catalepsy | Haloperidol | 3.73 | 1977408 15215559 | |
| MESH:D002386 | Cataract | Acetaminophen | 7.72 | 10977129 | |
| MESH:D002386 | Cataract | Adenosine Triphosphate | 7.72 | 15003327 | |
| MESH:D002386 | Cataract | Disulfiram | 7.72 | 17936468 15003327 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 2,6-dinitrotoluene | 24.76 | 6135515 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 4,4'-diaminodiphenylmethane | 24.76 | 7505956 | |
| MESH:D002471 | Cell Transformation, Neoplastic | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 24.76 | 20889678 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Acetylcysteine | 24.76 | 18226522 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cadmium | 24.76 | 17332340 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 24.76 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cytarabine | 24.76 | 8243401 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 24.76 | 18566989 | |
| MESH:D002471 | Cell Transformation, Neoplastic | sodium arsenite | 24.76 | 20056578 19524636 | |
| MESH:D002547 | Cerebral Palsy | Toluene | 4.65 | 9294310 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Testosterone | 4.13 | 20678186 | |
| MESH:D002659 | Child Development Disorders, Pervasive | Valproic Acid | 4.13 | 20734317 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 2.11 | 16835633 | |
| MESH:D002761 | Cholangitis | 1-Naphthylisothiocyanate | 4.99 | 12912871 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 3.96 | 11181007 | |
| MESH:D002779 | Cholestasis | 1-Naphthylisothiocyanate | 23.21 | 18590720 19486331 12927374 7624871 15500046 18164287 15913567 16629650 | |
| MESH:D002779 | Cholestasis | 4,4'-diaminodiphenylmethane | 23.21 | 9022650 19486331 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 23.21 | 19486331 | |
| MESH:D002779 | Cholestasis | estradiol-17 beta-glucuronide | 23.21 | 12893835 | |
| MESH:D002779 | Cholestasis | Ethinyl Estradiol | 23.21 | 16105132 17333356 16919318 11677210 17681005 17110522 15861022 | |
| MESH:D002779 | Cholestasis | Nitric Oxide | 23.21 | 16919318 | |
| MESH:D002779 | Cholestasis | Ursodeoxycholic Acid | 23.21 | 16487557 | |
| MESH:D002780 | Cholestasis, Intrahepatic | 1-Naphthylisothiocyanate | 10.65 | 19407337 10220858 | |
| MESH:D002780 | Cholestasis, Intrahepatic | Ursodeoxycholic Acid | 10.65 | 14728856 | |
| MESH:D015267 | Churg-Strauss Syndrome | zafirlukast | 5.18 | 9674492 | |
| MESH:D002971 | Cleft Lip | Folic Acid | 3.20 | 21254359 | |
| MESH:D002972 | Cleft Palate | Folic Acid | 3.79 | 21254359 8946559 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 3.79 | 15340226 16354765 8697196 12621046 15668235 | |
| MESH:D019970 | Cocaine-Related Disorders | Disulfiram | 4.55 | 19462300 | |
| MESH:D003072 | Cognition Disorders | Raloxifene | 3.45 | 15800139 | |
| MESH:D003092 | Colitis | Curcumin | 5.97 | 18200517 16782535 16804969 | |
| MESH:D003092 | Colitis | resveratrol | 5.97 | 16474422 | |
| MESH:D003103 | Coloboma | Curcumin | 3.45 | 18809619 | |
| MESH:D003110 | Colonic Neoplasms | arsenite | 25.84 | 15037631 | |
| MESH:D003110 | Colonic Neoplasms | Curcumin | 25.84 | 19359593 16340194 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 25.84 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Fluorouracil | 25.84 | 17169374 16510598 17287894 15001691 17172411 17725105 17016597 16340194 17018589 18772588 | |
| MESH:D003110 | Colonic Neoplasms | Genistein | 25.84 | 17182828 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 25.84 | 15963497 15786552 15637740 15625704 11260862 15936596 | |
| MESH:D003110 | Colonic Neoplasms | irinotecan | 25.84 | 17287894 17725105 | |
| MESH:D003110 | Colonic Neoplasms | Iron | 25.84 | 16640825 | |
| MESH:D003110 | Colonic Neoplasms | polyphenols | 25.84 | 16293270 | |
| MESH:D003110 | Colonic Neoplasms | Quercetin | 25.84 | 11134977 16640504 17191121 15741050 19056647 17148506 19440933 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 25.84 | 16338953 | |
| MESH:D003110 | Colonic Neoplasms | Sulindac | 25.84 | 12458338 12902858 | |
| MESH:D003110 | Colonic Neoplasms | zileuton | 25.84 | 18927292 | |
| MESH:D015179 | Colorectal Neoplasms | arsenic trioxide | 17.32 | 20501625 | |
| MESH:D015179 | Colorectal Neoplasms | Cisplatin | 17.32 | 15273666 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 17.32 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Fluorouracil | 17.32 | 16524972 16331619 18802399 14970324 16303861 15148649 16282729 15289873 20501625 17401013 17454858 18383874 17695437 17255274 18509181 17094418 17016601 16391804 18448328 18949393 18288408 17594712 | |
| MESH:D015179 | Colorectal Neoplasms | Folic Acid | 17.32 | 16963246 17116713 17087956 16985020 17245555 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 17.32 | 12606626 18059344 17054584 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | irinotecan | 17.32 | 17159606 18259882 16391804 15273666 18509181 17454858 16303861 | |
| MESH:D015179 | Colorectal Neoplasms | Isoflavones | 17.32 | 17116718 | |
| MESH:D015179 | Colorectal Neoplasms | Paclitaxel | 17.32 | 18802399 | |
| MESH:D015179 | Colorectal Neoplasms | Quercetin | 17.32 | 18852136 18095365 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 17.32 | 16550006 | |
| MESH:D015179 | Colorectal Neoplasms | Sulindac | 17.32 | 11076880 11197048 18059344 10666051 | |
| MESH:D015179 | Colorectal Neoplasms | Vinblastine | 17.32 | 18802399 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.01 | 14669216 17141729 | |
| MESH:D003233 | Conjunctivitis, Allergic | zafirlukast | 4.73 | 15351322 | |
| MESH:D016510 | Corneal Neovascularization | Curcumin | 3.72 | 18497527 | |
| MESH:D003327 | Coronary Disease | resveratrol | 2.86 | 16507316 | |
| MESH:D023903 | Coronary Restenosis | arsenic trioxide | 3.04 | 12609071 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.50 | 17302372 | |
| MESH:D003371 | Cough | zafirlukast | 4.44 | 12095178 | |
| MESH:D019465 | Craniofacial Abnormalities | arsenic trioxide | 7.21 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 7.21 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Methotrexate | 7.21 | 12039119 9562676 | |
| MESH:D019465 | Craniofacial Abnormalities | sodium arsenate | 7.21 | 10525206 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 7.21 | 15322242 20055451 10048152 | |
| MESH:D019465 | Craniofacial Abnormalities | Toluene | 7.21 | 9294310 | |
| MESH:D019465 | Craniofacial Abnormalities | Valproic Acid | 7.21 | 17688650 16575769 8888407 | |
| MESH:D016638 | Critical Illness | Estrogens | 4.75 | 16670151 | |
| MESH:D003490 | Cyanosis | 2,6-dinitrotoluene | 2.85 | 18551238 | |
| MESH:D003550 | Cystic Fibrosis | Acetylcysteine | 11.79 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Glutathione | 11.79 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | Methotrexate | 11.79 | 19747007 | |
| MESH:D003550 | Cystic Fibrosis | zafirlukast | 11.79 | 15463842 | |
| MESH:D003556 | Cystitis | Cyclophosphamide | 3.78 | 10498854 18295254 15276878 18710439 16614059 18483878 18433785 17979934 12913760 16651033 15643279 12161096 18093676 17010015 12388444 16413132 16989017 11948286 10700343 18372110 | |
| MESH:D007644 | Darier Disease | Fluorouracil | 3.60 | 16733453 | |
| MESH:D003643 | Death | Toluene | 4.46 | 6431079 | |
| MESH:D016757 | Death, Sudden, Cardiac | arsenic trioxide | 7.20 | 15213294 | |
| MESH:D016757 | Death, Sudden, Cardiac | Haloperidol | 7.20 | 20210726 | |
| MESH:D003665 | Decompression Sickness | zafirlukast | 10.70 | 18309904 | |
| MESH:D003665 | Decompression Sickness | zileuton | 10.70 | 18309904 | |
| MESH:D003704 | Dementia | Haloperidol | 3.49 | 11575062 | |
| MESH:D015140 | Dementia, Vascular | Nitric Oxide | 4.76 | 17556102 | |
| MESH:D003711 | Demyelinating Diseases | Tamoxifen | 3.19 | 19031437 | |
| MESH:D003866 | Depressive Disorder | venlafaxine | 3.90 | 20305041 | |
| MESH:D003865 | Depressive Disorder, Major | Raloxifene | 3.11 | 17474826 | |
| MESH:D017449 | Dermatitis, Allergic Contact | 4,4'-diaminodiphenylmethane | 7.46 | 18759878 8970840 12868966 11298694 8156756 11906362 14531868 2524372 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 7.46 | 12438553 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Mercury | 7.46 | 16823706 | |
| MESH:D017449 | Dermatitis, Allergic Contact | nickel sulfate | 7.46 | 16780908 16823706 11298694 | |
| MESH:D003876 | Dermatitis, Atopic | zafirlukast | 3.75 | 11901593 | |
| MESH:D003877 | Dermatitis, Contact | 4,4'-diaminodiphenylmethane | 2.39 | 3621924 2952479 | |
| MESH:D003882 | Dermatomyositis | Methotrexate | 3.98 | 20191521 | |
| MESH:D003920 | Diabetes Mellitus | Iron | 3.41 | 16640825 16604332 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Cyclophosphamide | 8.13 | 11751995 15331540 10990075 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | Quercetin | 8.13 | 19496084 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 8.13 | 16873680 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Cyclophosphamide | 4.05 | 18772604 | |
| MESH:D003922 | Diabetes Mellitus, Type 1 | Iron | 4.05 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Curcumin | 10.45 | 18403477 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | daidzein | 10.45 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Folic Acid | 10.45 | 16886840 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Genistein | 10.45 | 16647724 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Iron | 10.45 | 16506275 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 10.45 | 17107852 | |
| MESH:D003928 | Diabetic Nephropathies | Curcumin | 21.50 | 18204486 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 21.50 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 21.50 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | Raloxifene | 21.50 | 17451421 17308373 15920148 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 21.50 | 16286809 | |
| MESH:D003928 | Diabetic Nephropathies | Tamoxifen | 21.50 | 19279558 | |
| MESH:D003930 | Diabetic Retinopathy | Sulindac | 4.03 | 12861449 17621415 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 4.60 | 7237001 | |
| MESH:D003967 | Diarrhea | Indomethacin | 4.60 | 7237001 7907874 | |
| MESH:D004283 | Dog Diseases | Antimony | 4.47 | 12019027 | |
| MESH:D056486 | Drug-Induced Liver Injury | 1-Naphthylisothiocyanate | 30.35 | 17522070 18289764 7624871 20133375 | |
| MESH:D056486 | Drug-Induced Liver Injury | 2,6-dinitrotoluene | 30.35 | 21346803 18551238 | |
| MESH:D056486 | Drug-Induced Liver Injury | 4,4'-diaminodiphenylmethane | 30.35 | 11289319 1440618 18648102 16192314 9328219 7440962 8291058 9022650 9653073 18289764 6679447 18692083 6482804 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetaminophen | 30.35 | 17522070 16177239 11421492 11834606 11287661 15619225 19739265 19085960 10915739 19923254 16081117 12958197 15968718 12392966 16109766 12594235 17906064 2444490 12540782 19420014 10663392 10774834 19370779 19164858 18713872 16227642 11529661 14986274 16485898 12153990 12705907 17562736 18071297 16781746 11461765 11739529 16393943 19416960 14550746 14725611 11743745 | |
| MESH:D056486 | Drug-Induced Liver Injury | Acetylcysteine | 30.35 | 11287661 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 30.35 | 16177239 9327722 7440962 16227642 19336974 17522070 11566570 4309450 3732212 2869522 3786805 21278145 6623471 6884620 15968718 10915739 19085960 15027814 15998439 10092053 7120509 7179309 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 30.35 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Isoniazid | 30.35 | 16770646 14986274 17950035 | |
| MESH:D056486 | Drug-Induced Liver Injury | polyphenols | 30.35 | 19370779 | |
| MESH:D056486 | Drug-Induced Liver Injury | Silymarin | 30.35 | 14998559 | |
| MESH:D056486 | Drug-Induced Liver Injury | sodium arsenate | 30.35 | 18186108 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 30.35 | 20420201 | |
| MESH:D056486 | Drug-Induced Liver Injury | Valproic Acid | 30.35 | 19641884 1733752 | |
| MESH:D056486 | Drug-Induced Liver Injury | zafirlukast | 30.35 | 12583521 11119397 | |
| MESH:D056486 | Drug-Induced Liver Injury | zileuton | 30.35 | 17944539 | |
| MESH:D056487 | Drug-Induced Liver Injury, Chronic | Acetaminophen | 2.89 | 19426721 | |
| MESH:D004362 | Drug Toxicity | Cisplatin | 8.13 | 12649298 19839026 15033597 12231392 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 8.13 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 8.13 | 11462148 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 3.96 | 16133044 16326151 17190690 18446180 12774134 18043480 | |
| MESH:D004381 | Duodenal Ulcer | Curcumin | 5.67 | 17351913 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 5.67 | 17045617 17151854 16699067 11535926 10671773 17329845 17202747 17351913 11595431 11991626 11595415 | |
| MESH:D004417 | Dyspnea | Chlorine | 3.44 | 20016425 | |
| MESH:D004421 | Dystonia | Valproic Acid | 2.93 | 1851702 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.32 | 12438553 | |
| MESH:D004487 | Edema | bis(4-hydroxycinnamoyl)methane | 33.89 | 18449507 | |
| MESH:D004487 | Edema | demethoxycurcumin | 33.89 | 18449507 | |
| MESH:D004487 | Edema | Dexamethasone | 33.89 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 33.89 | 8985016 7907874 19703484 16100529 7990266 8273558 10653021 | |
| MESH:D004487 | Edema | Plant Extracts | 33.89 | 12787963 | |
| MESH:D004487 | Edema | Raloxifene | 33.89 | 15860553 | |
| MESH:D004487 | Edema | resveratrol | 33.89 | 8985016 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 33.89 | 11000095 12711302 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 33.89 | 16716910 9599246 15177302 8273558 11698051 7812673 8113982 | |
| MESH:D004487 | Edema | verlukast | 33.89 | 17118201 | |
| MESH:D004487 | Edema | zafirlukast | 33.89 | 15351322 | |
| MESH:D004487 | Edema | zileuton | 33.89 | 7990266 19703484 8273558 7812673 17118201 9831321 11698051 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 2.69 | 15322242 18230668 16714409 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | 15-deoxy-delta(12,14)-prostaglandin J2 | 16.89 | 16844232 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Ethinyl Estradiol | 16.89 | 12538720 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Raloxifene | 16.89 | 15845917 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 16.89 | 17872969 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | Tamoxifen | 16.89 | 19031437 | |
| MESH:D004714 | Endometrial Hyperplasia | Genistein | 3.40 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | daidzein | 17.46 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 17.46 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 17.46 | 11473722 18566989 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Folic Acid | 17.46 | 17301261 | |
| MESH:D016889 | Endometrial Neoplasms | Genistein | 17.46 | 11473722 | |
| MESH:D016889 | Endometrial Neoplasms | Tamoxifen | 17.46 | 19155303 20544844 16202921 17893378 | |
| MESH:D004715 | Endometriosis | Indomethacin | 13.20 | 15652904 | |
| MESH:D004715 | Endometriosis | Sulindac | 13.20 | 15652904 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 13.20 | 9294722 10568697 | |
| MESH:D004715 | Endometriosis | zafirlukast | 13.20 | 15019815 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 10.05 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 10.05 | 15268973 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 10.95 | 18509659 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 10.95 | 15821434 17637181 15328337 | |
| MESH:D019446 | Endotoxemia | zileuton | 10.95 | 15328337 | |
| MESH:D004751 | Enteritis | Indomethacin | 3.54 | 17763956 10567023 16328016 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 8.49 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 8.49 | 17923197 | |
| MESH:D004802 | Eosinophilia | Cyclophosphamide | 15.59 | 11006010 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 15.59 | 11298111 | |
| MESH:D004802 | Eosinophilia | montelukast | 15.59 | 10335014 | |
| MESH:D004802 | Eosinophilia | zafirlukast | 15.59 | 15696079 12742009 15351322 12689652 12189465 | |
| MESH:D004802 | Eosinophilia | zileuton | 15.59 | 10764316 8621850 | |
| MESH:D004831 | Epilepsies, Myoclonic | Valproic Acid | 2.99 | 17275665 3659116 | |
| MESH:D004828 | Epilepsies, Partial | Valproic Acid | 2.73 | 3922381 16628512 | |
| MESH:D004827 | Epilepsy | Pilocarpine | 6.76 | 11162239 19700373 19439326 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 6.76 | 19700373 19439326 | |
| MESH:D004827 | Epilepsy | Valproic Acid | 6.76 | 20417680 18234410 | |
| MESH:D004832 | Epilepsy, Absence | Valproic Acid | 2.55 | 6426943 7562514 6254150 | |
| MESH:D017029 | Epilepsy, Complex Partial | Valproic Acid | 3.13 | 7750514 | |
| MESH:D004830 | Epilepsy, Tonic-Clonic | Valproic Acid | 2.89 | 3659116 | |
| MESH:D007172 | Erectile Dysfunction | daidzein | 3.88 | 14972507 | |
| MESH:D004938 | Esophageal Neoplasms | 4,4'-diaminodiphenylmethane | 21.51 | 3581430 | |
| MESH:D004938 | Esophageal Neoplasms | 4-Nitroquinoline-1-oxide | 21.51 | 16543248 | |
| MESH:D004938 | Esophageal Neoplasms | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | 21.51 | 20426865 | |
| MESH:D004938 | Esophageal Neoplasms | arsenic trioxide | 21.51 | 12903497 | |
| MESH:D004938 | Esophageal Neoplasms | Cisplatin | 21.51 | 16481741 17638652 16785472 15173087 15464296 | |
| MESH:D004938 | Esophageal Neoplasms | docetaxel | 21.51 | 16337965 | |
| MESH:D004938 | Esophageal Neoplasms | Fluorouracil | 21.51 | 16785472 16481741 15173087 16337965 17638652 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 21.51 | 11005569 | |
| MESH:D004938 | Esophageal Neoplasms | Paclitaxel | 21.51 | 16481741 | |
| MESH:D004938 | Esophageal Neoplasms | Sulindac | 21.51 | 12235107 | |
| MESH:D017889 | Exfoliation Syndrome | Folic Acid | 4.30 | 16504073 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.03 | 11564622 | |
| MESH:D005234 | Fatty Liver | arsenic trioxide | 37.17 | 15073043 | |
| MESH:D005234 | Fatty Liver | arsenite | 37.17 | 18296743 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 37.17 | 19224547 16045604 61145 17595544 12795759 16239168 12631006 15959796 | |
| MESH:D005234 | Fatty Liver | Curcumin | 37.17 | 19297423 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 37.17 | 19224547 | |
| MESH:D005234 | Fatty Liver | Ethinyl Estradiol | 37.17 | 15345470 | |
| MESH:D005234 | Fatty Liver | Iron | 37.17 | 16640825 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 37.17 | 15975614 | |
| MESH:D005234 | Fatty Liver | Raloxifene | 37.17 | 17473493 | |
| MESH:D005234 | Fatty Liver | Tamoxifen | 37.17 | 14986274 19224547 | |
| MESH:D005234 | Fatty Liver | Valproic Acid | 37.17 | 14986274 19224547 | |
| MESH:D052776 | Female Urogenital Diseases | Tamoxifen | 2.37 | 16709447 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.30 | 11858732 | |
| MESH:D005315 | Fetal Diseases | Valproic Acid | 3.67 | 16575769 | |
| MESH:D005317 | Fetal Growth Retardation | Valproic Acid | 2.99 | 8888407 18558336 | |
| MESH:D005334 | Fever | Indomethacin | 5.80 | 11852909 10431976 17627676 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 5.80 | 9205823 11852909 | |
| MESH:D005350 | Fibroma | 4,4'-diaminodiphenylmethane | 3.80 | 6705139 | |
| MESH:D018221 | Fibromatosis, Abdominal | Sulindac | 9.01 | 14745880 | |
| MESH:D018221 | Fibromatosis, Abdominal | Tamoxifen | 9.01 | 14745880 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 12.72 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Sulindac | 12.72 | 19069698 | |
| MESH:D018222 | Fibromatosis, Aggressive | Tamoxifen | 12.72 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 3.71 | 10962813 | |
| MESH:D005355 | Fibrosis | arsenite | 28.63 | 18296743 | |
| MESH:D005355 | Fibrosis | baicalein | 28.63 | 19474275 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 28.63 | 18705752 | |
| MESH:D005355 | Fibrosis | Curcumin | 28.63 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 28.63 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Indomethacin | 28.63 | 17994277 | |
| MESH:D005355 | Fibrosis | Quercetin | 28.63 | 19474275 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 28.63 | 20067830 | |
| MESH:D005391 | Firesetting Behavior | Testosterone | 4.64 | 7506515 | |
| MESH:D005499 | Folliculitis | Clobetasol | 9.93 | 1671328 | |
| MESH:D005499 | Folliculitis | Indomethacin | 9.93 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 4.34 | 6392382 | |
| MESH:D005596 | Fractures, Closed | montelukast | 9.28 | 19544365 | |
| MESH:D005596 | Fractures, Closed | zileuton | 9.28 | 19544365 | |
| MESH:D005621 | Friedreich Ataxia | Iron | 4.25 | 16640825 16604332 | |
| MESH:D005706 | Gallbladder Neoplasms | arsenic trioxide | 3.12 | 16904648 | |
| MESH:D005739 | Gas Poisoning | Chlorine | 3.81 | 20016425 | |
| MESH:D005756 | Gastritis | Acetaminophen | 12.19 | 16983495 | |
| MESH:D005756 | Gastritis | Folic Acid | 12.19 | 17171786 | |
| MESH:D005756 | Gastritis | Indomethacin | 12.19 | 15046732 | |
| MESH:D005764 | Gastroesophageal Reflux | Sulindac | 3.87 | 11910360 | |
| MESH:D005770 | Gastrointestinal Neoplasms | Curcumin | 3.53 | 18462866 | |
| MESH:D005833 | Genital Neoplasms, Female | sodium arsenite | 3.49 | 16452187 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 3.03 | 8708960 | |
| MESH:D005901 | Glaucoma | Folic Acid | 3.95 | 16504073 | |
| MESH:D005909 | Glioblastoma | baicalein | 27.44 | 19804834 | |
| MESH:D005909 | Glioblastoma | biochanin A | 27.44 | 16598420 | |
| MESH:D005909 | Glioblastoma | Curcumin | 27.44 | 17596214 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 27.44 | 17150277 | |
| MESH:D005909 | Glioblastoma | Genistein | 27.44 | 16598420 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 27.44 | 12870263 | |
| MESH:D005909 | Glioblastoma | myricetin | 27.44 | 19804834 | |
| MESH:D005909 | Glioblastoma | Quercetin | 27.44 | 19804834 | |
| MESH:D005909 | Glioblastoma | Testosterone | 27.44 | 17162496 | |
| MESH:D005910 | Glioma | Fluorouracil | 6.03 | 16145905 | |
| MESH:D005910 | Glioma | Indomethacin | 6.03 | 18371953 16487511 | |
| MESH:D005910 | Glioma | Quercetin | 6.03 | 17643826 | |
| MESH:D018316 | Gliosarcoma | Cyclophosphamide | 4.32 | 11389073 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 3.27 | 11849393 | |
| MESH:D018149 | Glucose Intolerance | sodium arsenate | 3.95 | 19446573 | |
| MESH:D006030 | Glycosuria, Renal | Mercuric Chloride | 4.72 | 2918855 | |
| MESH:D006042 | Goiter | 4,4'-diaminodiphenylmethane | 2.91 | 7505956 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.38 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 4.16 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Cyclophosphamide | 8.29 | 11014644 16376943 15172196 | |
| MESH:D006086 | Graft vs Host Disease | Methotrexate | 8.29 | 16518429 | |
| MESH:D006261 | Headache | Nitric Oxide | 7.54 | 11554966 11284996 | |
| MESH:D006261 | Headache | zafirlukast | 7.54 | 9377612 10386485 | |
| MESH:D006258 | Head and Neck Neoplasms | Cisplatin | 14.48 | 15102660 15464296 | |
| MESH:D006258 | Head and Neck Neoplasms | Curcumin | 14.48 | 18829502 18462866 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 14.48 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Fluorouracil | 14.48 | 18337622 15102660 15162350 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 14.48 | 15482327 | |
| MESH:D034381 | Hearing Loss | Cisplatin | 3.24 | 19898482 | |
| MESH:D006319 | Hearing Loss, Sensorineural | Cisplatin | 3.38 | 15464296 | |
| MESH:D006330 | Heart Defects, Congenital | Folic Acid | 4.21 | 17286298 16524890 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 4.21 | 11294989 10048152 | |
| MESH:D006331 | Heart Diseases | marker/mechanism | 16330681 | ||
| MESH:D006331 | Heart Diseases | Doxorubicin | 4.74 | 16495754 17875725 17888722 16879835 16244371 16244372 18006777 16330681 16144979 12587719 18674790 16707910 14766674 | |
| MESH:D006331 | Heart Diseases | Raloxifene | 4.74 | 11110106 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 4.65 | 17481944 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 4.65 | 18097624 | |
| MESH:D006390 | Hemangioendothelioma | 2-Acetylaminofluorene | 4.11 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | 2-Acetylaminofluorene | 5.79 | 6705139 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 5.79 | 15692506 | |
| MESH:D006432 | Hemochromatosis | Iron | 3.52 | 17236123 16640825 17053826 16574947 17255318 16604332 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.23 | 15720958 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.30 | 16366002 | |
| MESH:D006467 | Hemophilia A | Cyclophosphamide | 4.12 | 11918545 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.24 | 11000095 | |
| MESH:D006486 | Hemosiderosis | Iron | 4.01 | 16604332 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.47 | 15633222 | |
| MESH:D006504 | Hepatic Veno-Occlusive Disease | Cyclophosphamide | 4.32 | 14986274 | |
| MESH:D006505 | Hepatitis | 1-Naphthylisothiocyanate | 13.25 | 18590720 | |
| MESH:D006505 | Hepatitis | 4,4'-diaminodiphenylmethane | 13.25 | 6705139 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 13.25 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | zafirlukast | 13.25 | 12189465 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.54 | 15135802 | |
| MESH:D006525 | Hepatitis, Viral, Human | Iron | 4.26 | 16640825 | |
| MESH:D006527 | Hepatolenticular Degeneration | Iron | 3.78 | 17182432 | |
| MESH:D006529 | Hepatomegaly | Iron | 8.13 | 16890145 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 8.13 | 15340226 12621046 16120746 | |
| MESH:D006529 | Hepatomegaly | zileuton | 8.13 | 8661344 | |
| MESH:D015417 | Hereditary Sensory and Motor Neuropathy | Curcumin | 3.87 | 17701891 | |
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 2.49 | 7520565 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 3.82 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Etoposide | 9.79 | 10809021 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 9.79 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 9.79 | 16876885 | |
| MESH:D006628 | Hirsutism | Testosterone | 4.44 | 17019078 | |
| MESH:D015658 | HIV Infections | Iron | 8.98 | 16597321 | |
| MESH:D015658 | HIV Infections | Nelfinavir | 8.98 | 15388451 11362904 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 8.98 | 12878215 | |
| MESH:D015658 | HIV Infections | Saquinavir | 8.98 | 11141242 15388451 | |
| MESH:D006679 | HIV Seropositivity | Folic Acid | 4.30 | 17209195 | |
| MESH:D006689 | Hodgkin Disease | Cisplatin | 26.11 | 16170182 16200630 | |
| MESH:D006689 | Hodgkin Disease | Cyclophosphamide | 26.11 | 17606976 16135485 | |
| MESH:D006689 | Hodgkin Disease | Cytarabine | 26.11 | 16200630 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 26.11 | 18501091 17606976 15147373 | |
| MESH:D006689 | Hodgkin Disease | Epirubicin | 26.11 | 18180244 | |
| MESH:D006689 | Hodgkin Disease | Etoposide | 26.11 | 15147373 16200630 17606976 18180244 16135485 | |
| MESH:D006689 | Hodgkin Disease | sodium arsenite | 26.11 | 12676792 | |
| MESH:D006689 | Hodgkin Disease | Vinblastine | 26.11 | 18501091 18180244 | |
| MESH:D006689 | Hodgkin Disease | Vincristine | 26.11 | 17606976 15147373 16794504 16135485 | |
| MESH:D019584 | Hot Flashes | Estradiol | 14.76 | 17088409 | |
| MESH:D019584 | Hot Flashes | Isoflavones | 14.76 | 17290160 14716179 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 14.76 | 16566672 17454163 14716179 | |
| MESH:D019584 | Hot Flashes | venlafaxine | 14.76 | 14716179 | |
| MESH:D006849 | Hydrocephalus | Valproic Acid | 3.67 | 17688650 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 2.84 | 15340226 16959395 18606429 16354765 8697196 | |
| MESH:D006930 | Hyperalgesia | Acetaminophen | 4.52 | 16870215 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 4.52 | 12727271 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.50 | 17883296 | |
| MESH:D017588 | Hyperandrogenism | Testosterone | 4.10 | 17019078 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.34 | 16899240 | |
| MESH:D006937 | Hypercholesterolemia | Curcumin | 5.77 | 18704882 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 5.77 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 8.78 | 12524144 | |
| MESH:D006940 | Hyperemia | Nitric Oxide | 8.78 | 11156591 | |
| MESH:D006943 | Hyperglycemia | kaempferol | 6.34 | 18262572 | |
| MESH:D006943 | Hyperglycemia | Quercetin | 6.34 | 18262572 11834736 | |
| MESH:D020138 | Hyperhomocysteinemia | Folic Acid | 6.25 | 16865747 16433478 16755160 16395265 16397167 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 6.25 | 16484555 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.37 | 17050553 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 9.22 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 9.22 | 15975614 15268973 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 9.22 | 16873680 | |
| MESH:D006965 | Hyperplasia | 4,4'-diaminodiphenylmethane | 2.78 | 15034207 | |
| MESH:D006973 | Hypertension | Arsenic | 20.85 | 16076760 11953799 9931084 | |
| MESH:D006973 | Hypertension | Cyclosporine | 20.85 | 10903974 | |
| MESH:D006973 | Hypertension | daidzein | 20.85 | 17169123 | |
| MESH:D006973 | Hypertension | Dexamethasone | 20.85 | 17042910 | |
| MESH:D006973 | Hypertension | Quercetin | 20.85 | 18356687 | |
| MESH:D006973 | Hypertension | Raloxifene | 20.85 | 15787275 17577099 | |
| MESH:D006973 | Hypertension | Sodium Chloride | 20.85 | 11507004 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 20.85 | 18850075 18670907 | |
| MESH:D006973 | Hypertension | Verapamil | 20.85 | 17700361 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 2.92 | 15338365 | |
| MESH:D006976 | Hypertension, Pulmonary | Nitric Oxide | 8.33 | 15838368 | |
| MESH:D006976 | Hypertension, Pulmonary | zafirlukast | 8.33 | 12781059 | |
| MESH:D006976 | Hypertension, Pulmonary | zileuton | 8.33 | 14726295 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 3.22 | 17488730 | |
| MESH:D006987 | Hypesthesia | Arsenic | 4.34 | 16093927 | |
| MESH:D007003 | Hypoglycemia | Glyburide | 4.83 | 10918110 | |
| MESH:D007006 | Hypogonadism | Iron | 6.46 | 16640825 | |
| MESH:D007006 | Hypogonadism | Testosterone | 6.46 | 12002444 | |
| MESH:D007018 | Hypopituitarism | Testosterone | 4.99 | 17426086 | |
| MESH:D007021 | Hypospadias | Ethinyl Estradiol | 2.64 | 16945680 16569931 | |
| MESH:D007037 | Hypothyroidism | Iron | 3.91 | 16640825 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 3.82 | 18306037 10574470 | |
| MESH:D007079 | Ileitis | Indomethacin | 4.16 | 16133968 10647630 10651667 | |
| MESH:D007154 | Immune System Diseases | Cyclophosphamide | 4.12 | 16076520 | |
| MESH:D007174 | Impulse Control Disorders | Testosterone | 4.64 | 7506515 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 4.16 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 8.07 | 17600658 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | zileuton | 8.07 | 19309543 | |
| MESH:D007247 | Infertility, Female | Ethinyl Estradiol | 2.35 | 12013081 | |
| MESH:D007248 | Infertility, Male | acetochlor | 11.57 | 12948887 | |
| MESH:D007248 | Infertility, Male | Cyclophosphamide | 11.57 | 7193160 16517039 | |
| MESH:D007248 | Infertility, Male | Ethinyl Estradiol | 11.57 | 17937319 | |
| MESH:D007248 | Infertility, Male | Methoxychlor | 11.57 | 16467254 11955947 | |
| MESH:D007248 | Infertility, Male | sodium arsenite | 11.57 | 15346721 12646999 | |
| MESH:D007249 | Inflammation | Curcumin | 42.71 | 18403477 17151092 16956363 | |
| MESH:D007249 | Inflammation | Dexamethasone | 42.71 | 11099482 8960868 | |
| MESH:D007249 | Inflammation | Flavonoids | 42.71 | 17296493 | |
| MESH:D007249 | Inflammation | Indomethacin | 42.71 | 12568917 3291741 7812673 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 42.71 | 17237260 17255318 12878042 9205823 17963957 | |
| MESH:D007249 | Inflammation | montelukast | 42.71 | 18059327 | |
| MESH:D007249 | Inflammation | Plant Extracts | 42.71 | 15997105 12787963 19332304 16366677 | |
| MESH:D007249 | Inflammation | polyphenols | 42.71 | 16366677 | |
| MESH:D007249 | Inflammation | resveratrol | 42.71 | 16366677 | |
| MESH:D007249 | Inflammation | Silymarin | 42.71 | 17213517 | |
| MESH:D007249 | Inflammation | Sulindac | 42.71 | 3291741 | |
| MESH:D007249 | Inflammation | Tamoxifen | 42.71 | 19457130 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 42.71 | 12200463 12878042 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 42.71 | 8273558 7562506 15177302 11698051 7812673 | |
| MESH:D007249 | Inflammation | verlukast | 42.71 | 17118201 | |
| MESH:D007249 | Inflammation | zafirlukast | 42.71 | 11438310 18309904 | |
| MESH:D007249 | Inflammation | zileuton | 42.71 | 9831321 18309904 8960868 7812673 18059327 8621850 17118201 18295198 | |
| MESH:D015212 | Inflammatory Bowel Diseases | Curcumin | 4.63 | 18596194 18200517 | |
| MESH:D015212 | Inflammatory Bowel Diseases | zileuton | 4.63 | 15339030 | |
| MESH:D007251 | Influenza, Human | Quercetin | 7.21 | 16624496 | |
| MESH:D007251 | Influenza, Human | resveratrol | 7.21 | 16624496 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 2.09 | 16627594 16393666 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 6.48 | 15831440 18236018 11686837 17329856 11855677 15610444 17994277 11713966 10210152 | |
| MESH:D007410 | Intestinal Diseases | Nitric Oxide | 6.48 | 11574821 11713966 10210152 | |
| MESH:D007414 | Intestinal Neoplasms | caffeic acid phenethyl ester | 14.62 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Curcumin | 14.62 | 10783313 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 14.62 | 12351151 12584176 12628509 | |
| MESH:D007414 | Intestinal Neoplasms | Sulindac | 14.62 | 10213222 12663524 12628509 12584176 12351151 10223192 | |
| MESH:D007417 | Intestinal Polyps | Sulindac | 3.86 | 11245490 12394442 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 4.16 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Iron | 7.86 | 17163184 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 7.86 | 17255318 | |
| MESH:D007511 | Ischemia | morin | 4.76 | 16806951 | |
| MESH:D007565 | Jaundice | 4,4'-diaminodiphenylmethane | 3.80 | 8074119 9022650 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 2.24 | 16580747 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 3.82 | 16133968 18306037 10574470 | |
| MESH:D007627 | Keloid | Quercetin | 3.78 | 17086741 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.23 | 15604871 | |
| MESH:D007642 | Keratosis | Arsenic | 3.80 | 16930632 12749816 | |
| MESH:D007673 | Kidney Cortex Necrosis | Cisplatin | 3.93 | 15464296 | |
| MESH:D007674 | Kidney Diseases | Acetaminophen | 33.25 | 15629191 12587719 | |
| MESH:D007674 | Kidney Diseases | Cadmium | 33.25 | 16322080 16962696 16226777 | |
| MESH:D007674 | Kidney Diseases | caffeic acid phenethyl ester | 33.25 | 15369732 | |
| MESH:D007674 | Kidney Diseases | Cisplatin | 33.25 | 18289764 12231392 15190930 12649298 19839026 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 33.25 | 8314463 18776723 10903974 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 33.25 | 15369732 15699352 16775033 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 33.25 | 15618244 | |
| MESH:D007674 | Kidney Diseases | ferric nitrilotriacetate | 33.25 | 18617210 15834431 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 33.25 | 17190690 | |
| MESH:D007674 | Kidney Diseases | Mercury | 33.25 | 17934191 | |
| MESH:D007674 | Kidney Diseases | Quercetin | 33.25 | 16962696 | |
| MESH:D007674 | Kidney Diseases | sodium arsenite | 33.25 | 20008137 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 3.06 | 16707910 | |
| MESH:D007680 | Kidney Neoplasms | 2,6-dinitrotoluene | 19.63 | 16705839 | |
| MESH:D007680 | Kidney Neoplasms | 4,4'-diaminodiphenylmethane | 19.63 | 6582329 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 19.63 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 19.63 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | ferric nitrilotriacetate | 19.63 | 18055543 9667754 | |
| MESH:D007680 | Kidney Neoplasms | Fluorouracil | 19.63 | 16985049 | |
| MESH:D007680 | Kidney Neoplasms | Tamoxifen | 19.63 | 18625569 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Cisplatin | 3.59 | 11231351 | |
| MESH:D007805 | Language Development Disorders | Methotrexate | 3.97 | 9562676 | |
| MESH:D007859 | Learning Disorders | Colchicine | 4.36 | 11749816 | |
| MESH:D007889 | Leiomyoma | Curcumin | 7.43 | 18555241 | |
| MESH:D007889 | Leiomyoma | Raloxifene | 7.43 | 16973256 | |
| MESH:D007896 | Leishmaniasis | Antimony | 6.18 | 21063981 10953559 21182181 15220340 12019027 | |
| MESH:D007896 | Leishmaniasis | Nitric Oxide | 6.18 | 17218153 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Antimony | 8.39 | 11475954 8889330 19141829 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 8.39 | 11703811 12228301 10320625 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Sodium Chloride | 8.39 | 9499605 | |
| MESH:D007897 | Leishmaniasis, Mucocutaneous | Antimony | 4.30 | 10651420 11370249 9643325 10881086 7854095 | |
| MESH:D007898 | Leishmaniasis, Visceral | Antimony | 5.48 | 1899875 7875148 8142506 7554475 20495762 7854095 11105143 | |
| MESH:D007898 | Leishmaniasis, Visceral | Antimony Potassium Tartrate | 5.48 | 12707265 | |
| MESH:D007938 | Leukemia | arsenic trioxide | 14.58 | 15070760 | |
| MESH:D007938 | Leukemia | Curcumin | 14.58 | 18462866 | |
| MESH:D007938 | Leukemia | Cyclophosphamide | 14.58 | 10602166 | |
| MESH:D007938 | Leukemia | Genistein | 14.58 | 18980019 17468513 | |
| MESH:D007938 | Leukemia | kaempferol | 14.58 | 17468513 | |
| MESH:D007938 | Leukemia | Quercetin | 14.58 | 17468513 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 3.94 | 16085563 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Cyclophosphamide | 4.77 | 17296974 17802794 18172266 17008537 18587576 17658394 | |
| MESH:D015451 | Leukemia, Lymphocytic, Chronic, B-Cell | Disulfiram | 4.77 | 17026967 | |
| MESH:D007945 | Leukemia, Lymphoid | Thiotepa | 5.09 | 10069464 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | arsenic trioxide | 6.13 | 17077332 12560223 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Curcumin | 6.13 | 16106398 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | arsenic trioxide | 7.82 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 7.82 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | arsenic trioxide | 15.99 | 14633726 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Cyclophosphamide | 15.99 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 15.99 | 16572323 15631656 10785260 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Thiotepa | 15.99 | 10373061 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | zileuton | 15.99 | 19823023 19503090 | |
| MESH:D007951 | Leukemia, Myeloid | arsenic trioxide | 6.52 | 19077051 | |
| MESH:D007951 | Leukemia, Myeloid | Thiotepa | 6.52 | 10069464 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | arsenic trioxide | 5.39 | 20471514 16968895 17050201 19850784 16467208 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Idarubicin | 5.39 | 16271486 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 5.39 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Valproic Acid | 5.39 | 16294345 17596541 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Antimony Potassium Tartrate | 18.06 | 9834237 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 18.06 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | arsenic trioxide | 18.06 | 12712474 11468182 17649720 19035177 17712046 16330433 16891316 15748426 15213294 12018890 17107899 16112521 9834237 16331271 16823087 17217047 19642359 16966277 15622746 12679006 19075265 11161223 15336539 17869043 19225113 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | caffeic acid phenethyl ester | 18.06 | 16766008 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Idarubicin | 18.06 | 17712046 17107899 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 18.06 | 16087638 | |
| MESH:D015458 | Leukemia, T-Cell | arsenic trioxide | 7.91 | 16882451 | |
| MESH:D015458 | Leukemia, T-Cell | Curcumin | 7.91 | 16106398 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 10.39 | 16537180 | |
| MESH:D007964 | Leukocytosis | zafirlukast | 10.39 | 18489783 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.50 | 17980183 | |
| MESH:D007970 | Leukopenia | Cyclophosphamide | 7.83 | 10052129 11830472 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 7.83 | 15821434 | |
| MESH:D020961 | Lewy Body Disease | Iron | 4.25 | 16563566 | |
| MESH:D017880 | Limb Deformities, Congenital | Disulfiram | 3.78 | 17676605 | |
| MESH:D008064 | Lipidoses | chlorcyclizine | 5.41 | 15342952 | |
| MESH:D008064 | Lipidoses | Tamoxifen | 5.41 | 17567588 15342952 | |
| MESH:D008080 | Liposarcoma | Paclitaxel | 3.70 | 17353645 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.50 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | arsenite | 15.30 | 18296743 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 15.30 | 16221502 17157831 21278145 11903743 17174718 16943688 17334410 11408273 16239168 | |
| MESH:D008103 | Liver Cirrhosis | Iron | 15.30 | 16640825 | |
| MESH:D008103 | Liver Cirrhosis | Methotrexate | 15.30 | 14986274 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 15.30 | 17157831 | |
| MESH:D008103 | Liver Cirrhosis | Silymarin | 15.30 | 17213517 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | 4,4'-diaminodiphenylmethane | 8.99 | 9327722 15034207 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Sulindac | 8.99 | 12468960 | |
| MESH:D008105 | Liver Cirrhosis, Biliary | Ursodeoxycholic Acid | 8.99 | 12468960 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 23.23 | 14620537 14716833 16027843 17922224 18412020 16136751 18376398 18420326 17721639 15931870 15876570 15370692 12445421 17823541 17640975 12445418 14716496 16015684 18395914 16033810 12389079 18395095 18205269 16638106 17698563 18472332 15818738 18277467 15925388 18054572 13678700 18472094 16248980 12649538 12667390 12666154 18006644 20821823 18429990 14748882 15338365 16097048 17525996 17900296 18210741 14512876 12546737 17869086 17557913 11481614 15673190 17481882 17761835 18481824 17805973 12609069 12898905 14724832 17714472 12741479 18156304 15123356 18279442 17766677 15730626 16011737 18418968 18263696 17708605 15362042 18251166 18187930 12632514 18339082 10355542 15959796 18317297 17944888 17631135 16192424 12632512 18705752 15057751 16116963 15650968 17976157 15893842 15052691 17565644 15996030 12958196 12586293 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Curcumin | 23.23 | 17355460 18006644 18705752 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 23.23 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 23.23 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 23.23 | 14659978 14716833 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Genistein | 23.23 | 17823541 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Heparin | 23.23 | 16904936 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 23.23 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 23.23 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | morin | 23.23 | 18629640 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | naringenin | 23.23 | 14709902 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 23.23 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Quercetin | 23.23 | 12741479 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Silymarin | 23.23 | 15754394 17198567 15864749 18277467 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tamoxifen | 23.23 | 18564211 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 23.23 | 12878042 | |
| MESH:D008107 | Liver Diseases | 1-Naphthylisothiocyanate | 21.47 | 17184895 | |
| MESH:D008107 | Liver Diseases | Acetaminophen | 21.47 | 12969438 19460945 16611625 12587719 19784758 19014921 16610002 11587558 | |
| MESH:D008107 | Liver Diseases | Arsenic | 21.47 | 11134558 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 21.47 | 15830285 15720792 16246199 16964402 17285989 | |
| MESH:D008107 | Liver Diseases | Curcumin | 21.47 | 16956363 | |
| MESH:D008107 | Liver Diseases | Folic Acid | 21.47 | 16877991 | |
| MESH:D008107 | Liver Diseases | naringenin | 21.47 | 16945181 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 21.47 | 17034775 | |
| MESH:D008107 | Liver Diseases | polyphenols | 21.47 | 16698588 | |
| MESH:D008107 | Liver Diseases | Silymarin | 21.47 | 17213517 | |
| MESH:D008107 | Liver Diseases | Sulindac | 21.47 | 16867024 14986274 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Iron | 8.09 | 16737972 17207112 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Silymarin | 8.09 | 17213517 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 3.00 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Acetaminophen | 10.19 | 16871587 17185352 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 10.19 | 16899240 14706259 | |
| MESH:D017114 | Liver Failure, Acute | venlafaxine | 10.19 | 19857765 | |
| MESH:D008113 | Liver Neoplasms | 2,6-dinitrotoluene | 38.12 | 7678174 | |
| MESH:D008113 | Liver Neoplasms | 2-Acetylaminofluorene | 38.12 | 11376686 10737359 16273603 10672840 14678523 18001218 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 38.12 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | arsenic trioxide | 38.12 | 14682389 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 38.12 | 19389873 21295105 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 38.12 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Fluorouracil | 38.12 | 15113037 16603448 18383874 17045692 | |
| MESH:D008113 | Liver Neoplasms | Iron | 38.12 | 20302851 16640825 | |
| MESH:D008113 | Liver Neoplasms | Mitomycin | 38.12 | 15113037 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 38.12 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | Quercetin | 38.12 | 18980244 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 38.12 | 19073162 20405173 19812893 19321006 | |
| MESH:D008113 | Liver Neoplasms | Silymarin | 38.12 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | sodium arsenite | 38.12 | 15276417 16712894 | |
| MESH:D008113 | Liver Neoplasms | Tamoxifen | 38.12 | 16684651 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 38.12 | 16984957 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2,6-dinitrotoluene | 24.38 | 6135515 2876786 2876784 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 2-Acetylaminofluorene | 24.38 | 534488 6150874 1399818 | |
| MESH:D008114 | Liver Neoplasms, Experimental | 4,4'-diaminodiphenylmethane | 24.38 | 598648 6587162 1399818 3712494 | |
| MESH:D008114 | Liver Neoplasms, Experimental | arsenic trioxide | 24.38 | 20377131 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 24.38 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 24.38 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 24.38 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | morin | 24.38 | 19539802 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Quercetin | 24.38 | 19519916 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 24.38 | 12151625 | |
| MESH:D008133 | Long QT Syndrome | arsenic trioxide | 5.42 | 15213294 | |
| MESH:D008133 | Long QT Syndrome | Quinidine | 5.42 | 11989578 15350150 | |
| MESH:D008171 | Lung Diseases | Acetylcysteine | 7.16 | 12815614 | |
| MESH:D008171 | Lung Diseases | Ozone | 7.16 | 8266340 19066396 | |
| MESH:D008171 | Lung Diseases | sodium arsenite | 7.16 | 19095001 | |
| MESH:D017563 | Lung Diseases, Interstitial | Methotrexate | 7.47 | 18516814 | |
| MESH:D017563 | Lung Diseases, Interstitial | Valproic Acid | 7.47 | 17228818 | |
| MESH:D008173 | Lung Diseases, Obstructive | zafirlukast | 4.83 | 9847434 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 8.71 | 21114838 | |
| MESH:D055370 | Lung Injury | Nitric Oxide | 8.71 | 11395602 | |
| MESH:D055370 | Lung Injury | Ozone | 8.71 | 20417186 | |
| MESH:D008175 | Lung Neoplasms | 2-Acetylaminofluorene | 32.34 | 11376686 | |
| MESH:D008175 | Lung Neoplasms | Arsenic | 32.34 | 19168569 17976673 17306315 | |
| MESH:D008175 | Lung Neoplasms | arsenic trioxide | 32.34 | 11798837 19825857 | |
| MESH:D008175 | Lung Neoplasms | arsenite | 32.34 | 16809336 | |
| MESH:D008175 | Lung Neoplasms | Cisplatin | 32.34 | 17225452 6189445 11798837 | |
| MESH:D008175 | Lung Neoplasms | Curcumin | 32.34 | 19359593 18462866 16243823 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 32.34 | 15824018 11195469 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 32.34 | 6189445 17418594 | |
| MESH:D008175 | Lung Neoplasms | Fluorouracil | 32.34 | 15246190 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 32.34 | 11053908 11497255 16537180 | |
| MESH:D008175 | Lung Neoplasms | Iron | 32.34 | 16640825 | |
| MESH:D008175 | Lung Neoplasms | Ozone | 32.34 | 8597069 7614698 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 32.34 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Quercetin | 32.34 | 16280456 | |
| MESH:D008175 | Lung Neoplasms | sodium arsenite | 32.34 | 15276417 16712894 17306315 19931552 17077188 | |
| MESH:D008175 | Lung Neoplasms | Sulindac | 32.34 | 15713900 19359593 | |
| MESH:D008175 | Lung Neoplasms | Tamoxifen | 32.34 | 18625569 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 32.34 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 32.34 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Vincristine | 32.34 | 19825857 6189445 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Fluorouracil | 9.34 | 15086387 | |
| MESH:D008178 | Lupus Erythematosus, Cutaneous | Rifampin | 9.34 | 11422169 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Folic Acid | 4.25 | 17718048 | |
| MESH:D008180 | Lupus Erythematosus, Systemic | Rifampin | 4.25 | 11422169 | |
| MESH:D008223 | Lymphoma | Chlorambucil | 24.72 | 10745627 | |
| MESH:D008223 | Lymphoma | Curcumin | 24.72 | 18462866 | |
| MESH:D008223 | Lymphoma | Cyclophosphamide | 24.72 | 12854902 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 24.72 | 16098063 | |
| MESH:D008223 | Lymphoma | Etoposide | 24.72 | 12854902 12556972 | |
| MESH:D008223 | Lymphoma | Methotrexate | 24.72 | 17352296 | |
| MESH:D008223 | Lymphoma | Nitric Oxide | 24.72 | 16166326 | |
| MESH:D008223 | Lymphoma | Thiotepa | 24.72 | 10069464 | |
| MESH:D016393 | Lymphoma, B-Cell | Cyclophosphamide | 6.76 | 16675587 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 6.76 | 17088997 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Cyclophosphamide | 12.31 | 11911406 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 12.31 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Paclitaxel | 12.31 | 14749477 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 12.31 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Curcumin | 7.69 | 16173963 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 7.69 | 15621674 | |
| MESH:D008268 | Macular Degeneration | Iron | 3.17 | 16640825 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 6.10 | 15688416 | |
| MESH:D015674 | Mammary Neoplasms, Animal | Tamoxifen | 6.10 | 19428831 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | 5,6-dimethylxanthenoneacetic acid | 21.16 | 16944150 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 21.16 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 21.16 | 17203775 11807958 11408345 16891317 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Genistein | 21.16 | 14578162 12929590 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 21.16 | 8985016 11606380 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | selenomethylselenocysteine | 21.16 | 15318939 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tamoxifen | 21.16 | 14580682 19196723 11731420 16827153 19196722 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 21.16 | 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tocopherols | 21.16 | 17927505 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 8.64 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Tamoxifen | 8.64 | 19453300 | |
| MESH:D019767 | Maxillofacial Abnormalities | Folic Acid | 4.50 | 16832597 | |
| MESH:D008545 | Melanoma | Cisplatin | 25.38 | 17761969 18332650 16809738 16248763 18505091 12883367 17023156 12374674 16432458 18176117 11135225 15577323 12393984 | |
| MESH:D008545 | Melanoma | Curcumin | 25.38 | 18462866 17885582 | |
| MESH:D008545 | Melanoma | Disulfiram | 25.38 | 15367699 | |
| MESH:D008545 | Melanoma | docetaxel | 25.38 | 12417787 | |
| MESH:D008545 | Melanoma | Doxorubicin | 25.38 | 16827129 | |
| MESH:D008545 | Melanoma | Epirubicin | 25.38 | 16642371 | |
| MESH:D008545 | Melanoma | Glucose | 25.38 | 14993021 | |
| MESH:D008545 | Melanoma | Melphalan | 25.38 | 18388930 14993021 | |
| MESH:D008545 | Melanoma | Paclitaxel | 25.38 | 16342250 12025231 12040289 | |
| MESH:D008545 | Melanoma | resveratrol | 25.38 | 17992120 | |
| MESH:D008545 | Melanoma | sodium arsenite | 25.38 | 16487513 19082730 | |
| MESH:D008545 | Melanoma | Sulindac | 25.38 | 16642371 | |
| MESH:D008545 | Melanoma | Tamoxifen | 25.38 | 12393984 19393235 | |
| MESH:D008545 | Melanoma | Vinblastine | 25.38 | 15577323 16809738 16248763 18505091 18332650 16432458 17761969 18176117 12374674 15577320 | |
| MESH:D018328 | Melanoma, Amelanotic | Cisplatin | 12.84 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Tamoxifen | 12.84 | 15990972 | |
| MESH:D018328 | Melanoma, Amelanotic | Vincristine | 12.84 | 15990972 | |
| MESH:D008546 | Melanoma, Experimental | Acetaminophen | 6.97 | 19513568 | |
| MESH:D008546 | Melanoma, Experimental | Cyclophosphamide | 6.97 | 16388313 | |
| MESH:D008569 | Memory Disorders | Curcumin | 3.03 | 17263510 | |
| MESH:D001523 | Mental Disorders | Haloperidol | 4.92 | 16856516 | |
| MESH:D001523 | Mental Disorders | venlafaxine | 4.92 | 16856516 | |
| MESH:D008607 | Mental Retardation | Toluene | 3.08 | 9294310 | |
| MESH:D008654 | Mesothelioma | Cisplatin | 6.44 | 17638057 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 6.44 | 17638057 | |
| MESH:D008654 | Mesothelioma | Tocopherols | 6.44 | 15878867 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 3.28 | 17112576 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.57 | 16801185 | |
| MESH:D008679 | Metaplasia | Ozone | 3.89 | 10496685 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 17.04 | 11903285 | |
| MESH:D008881 | Migraine Disorders | montelukast | 17.04 | 10759916 | |
| MESH:D008881 | Migraine Disorders | Nitric Oxide | 17.04 | 11701602 | |
| MESH:D008881 | Migraine Disorders | Valproic Acid | 17.04 | 18765137 18803445 | |
| MESH:D008881 | Migraine Disorders | venlafaxine | 17.04 | 18803445 | |
| MESH:D008881 | Migraine Disorders | zafirlukast | 17.04 | 10759916 | |
| MESH:D020326 | Migraine without Aura | Nitric Oxide | 3.97 | 11304026 14659530 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.39 | 15792986 | |
| MESH:D018200 | Mixed Tumor, Mullerian | Raloxifene | 4.34 | 15863610 | |
| MESH:D019957 | Motor Skills Disorders | Toluene | 4.11 | 9294310 | |
| MESH:D009062 | Mouth Neoplasms | Fluorouracil | 5.52 | 16757204 18986760 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 5.52 | 12636206 | |
| MESH:D052016 | Mucositis | Doxorubicin | 14.29 | 17415656 | |
| MESH:D052016 | Mucositis | irinotecan | 14.29 | 17159606 | |
| MESH:D052016 | Mucositis | Methotrexate | 14.29 | 17488658 | |
| MESH:D009101 | Multiple Myeloma | arsenic trioxide | 16.08 | 14977855 19417148 15949261 11468182 19549372 | |
| MESH:D009101 | Multiple Myeloma | Curcumin | 16.08 | 19372569 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 16.08 | 15867202 16118317 15744524 | |
| MESH:D009101 | Multiple Myeloma | Paclitaxel | 16.08 | 14749477 | |
| MESH:D009101 | Multiple Myeloma | Raloxifene | 16.08 | 16497877 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 16.08 | 16267019 17049120 17164350 14749477 16490592 17935668 | |
| MESH:D020528 | Multiple Sclerosis, Chronic Progressive | Iron | 4.46 | 17086897 | |
| MESH:D009134 | Muscular Atrophy, Spinal | Curcumin | 8.47 | 17962980 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 8.47 | 17962980 | |
| MESH:D009139 | Musculoskeletal Abnormalities | sodium arsenate | 7.03 | 18186108 | |
| MESH:D009139 | Musculoskeletal Abnormalities | Valproic Acid | 7.03 | 8888407 | |
| MESH:D009145 | Mushroom Poisoning | Silymarin | 5.72 | 17213517 | |
| MESH:D009164 | Mycobacterium Infections | Isoniazid | 7.82 | 18474467 | |
| MESH:D009164 | Mycobacterium Infections | Rifampin | 7.82 | 18474467 | |
| MESH:D009181 | Mycoses | Iron | 4.26 | 16640825 | |
| MESH:D009182 | Mycosis Fungoides | arsenic trioxide | 3.46 | 18349030 | |
| MESH:D009190 | Myelodysplastic Syndromes | arsenic trioxide | 7.46 | 16105982 16882451 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 7.46 | 9809623 | |
| MESH:D009190 | Myelodysplastic Syndromes | Valproic Acid | 7.46 | 17596541 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 10.47 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Genistein | 10.47 | 17141266 | |
| MESH:D009203 | Myocardial Infarction | Quercetin | 10.47 | 19595682 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 10.47 | 17125593 17188708 16456233 16525036 16317513 17015251 | |
| MESH:D009203 | Myocardial Infarction | Vincristine | 10.47 | 17284715 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 13.57 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | Iron | 13.57 | 16604332 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 13.57 | 17015251 17125593 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 13.57 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 12.24 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Genistein | 12.24 | 17141266 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Iron | 12.24 | 16604332 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Quercetin | 12.24 | 19207477 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.57 | 17322642 | |
| MESH:D009232 | Myxoma | Raloxifene | 4.34 | 16343187 | |
| MESH:D009298 | Nasal Polyps | zafirlukast | 10.70 | 10665187 12053594 | |
| MESH:D009298 | Nasal Polyps | zileuton | 10.70 | 10665187 | |
| MESH:D009325 | Nausea | zafirlukast | 4.64 | 10386485 | |
| MESH:D009336 | Necrosis | 2,6-dinitrotoluene | 7.06 | 7678174 18551238 | |
| MESH:D009336 | Necrosis | zafirlukast | 7.06 | 15028970 | |
| MESH:D009361 | Neoplasm Invasiveness | arsenic trioxide | 20.39 | 16624393 | |
| MESH:D009361 | Neoplasm Invasiveness | bis(4-hydroxycinnamoyl)methane | 20.39 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Curcumin | 20.39 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | demethoxycurcumin | 20.39 | 18495463 | |
| MESH:D009361 | Neoplasm Invasiveness | Disulfiram | 20.39 | 18047805 | |
| MESH:D009362 | Neoplasm Metastasis | 4,4'-diaminodiphenylmethane | 19.95 | 3581430 | |
| MESH:D009362 | Neoplasm Metastasis | Acetylcysteine | 19.95 | 14720322 | |
| MESH:D009362 | Neoplasm Metastasis | Disulfiram | 19.95 | 15367699 | |
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 19.95 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 19.95 | 11239499 16537180 11053908 | |
| MESH:D009362 | Neoplasm Metastasis | irinotecan | 19.95 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Paclitaxel | 19.95 | 15867366 | |
| MESH:D009362 | Neoplasm Metastasis | Tamoxifen | 19.95 | 19393235 | |
| MESH:D009364 | Neoplasm Recurrence, Local | Tamoxifen | 1.96 | 19410462 | |
| MESH:D009369 | Neoplasms | Cisplatin | 17.64 | 16773208 | |
| MESH:D009369 | Neoplasms | Cyclophosphamide | 17.64 | 18854779 | |
| MESH:D009369 | Neoplasms | Disulfiram | 17.64 | 17079463 | |
| MESH:D009369 | Neoplasms | Fluorouracil | 17.64 | 18600527 16928823 18239605 | |
| MESH:D009369 | Neoplasms | methoxy-morpholinyl-doxorubicin | 17.64 | 15465924 | |
| MESH:D009369 | Neoplasms | naringenin | 17.64 | 15185748 | |
| MESH:D009369 | Neoplasms | Quercetin | 17.64 | 15185748 | |
| MESH:D009369 | Neoplasms | sodium arsenite | 17.64 | 11559025 | |
| MESH:D009369 | Neoplasms | Thiotepa | 17.64 | 18854779 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 8.72 | 10663608 15625704 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 8.72 | 8985016 | |
| MESH:D009374 | Neoplasms, Experimental | sodium arsenite | 8.72 | 20056578 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Curcumin | 6.86 | 12497104 | |
| MESH:D009376 | Neoplasms, Hormone-Dependent | Tamoxifen | 6.86 | 19200415 19189210 19196722 | |
| MESH:D009389 | Neovascularization, Pathologic | arsenite | 10.37 | 15738583 | |
| MESH:D009389 | Neovascularization, Pathologic | Disulfiram | 10.37 | 15367699 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 10.37 | 17289903 | |
| MESH:D009395 | Nephritis, Interstitial | Cisplatin | 3.30 | 15464296 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.60 | 16899518 16636307 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.23 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 9.72 | 19348381 18481113 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 9.72 | 16889571 15640375 | |
| MESH:D009404 | Nephrotic Syndrome | Iron | 9.72 | 17178036 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 14.27 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Genistein | 14.27 | 16427766 | |
| MESH:D009421 | Nervous System Malformations | Pilocarpine | 14.27 | 15987249 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 14.27 | 14600291 | |
| MESH:D009423 | Nervous System Neoplasms | Curcumin | 4.42 | 18462866 | |
| MESH:D009436 | Neural Tube Defects | 4,4'-diaminodiphenylmethane | 24.37 | 6679447 | |
| MESH:D009436 | Neural Tube Defects | Acetylcysteine | 24.37 | 19446573 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 24.37 | 16620997 | |
| MESH:D009436 | Neural Tube Defects | arsenic trioxide | 24.37 | 10525206 | |
| MESH:D009436 | Neural Tube Defects | Folic Acid | 24.37 | 17438019 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenate | 24.37 | 18186108 11749123 10525206 19446573 | |
| MESH:D009436 | Neural Tube Defects | sodium arsenite | 24.37 | 12854658 | |
| MESH:D009436 | Neural Tube Defects | Valproic Acid | 24.37 | 16359493 8888407 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 4.01 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Cisplatin | 12.95 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Cyclophosphamide | 12.95 | 16115947 8761367 15176712 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 12.95 | 15555623 | |
| MESH:D009447 | Neuroblastoma | irinotecan | 12.95 | 8761367 | |
| MESH:D009447 | Neuroblastoma | Thiotepa | 12.95 | 8761367 | |
| MESH:D019636 | Neurodegenerative Diseases | Acetaminophen | 15.57 | 18514411 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 15.57 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | Iron | 15.57 | 17296847 16604332 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 15.57 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Sulindac | 15.57 | 16850258 17266991 | |
| MESH:D017599 | Neuroectodermal Tumors | Cisplatin | 23.48 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Cyclophosphamide | 23.48 | 12837982 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | irinotecan | 23.48 | 8761367 | |
| MESH:D017599 | Neuroectodermal Tumors | Thiotepa | 23.48 | 8761367 12837982 | |
| MESH:D017599 | Neuroectodermal Tumors | Vincristine | 23.48 | 12837982 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 11.36 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | Quercetin | 11.36 | 17929310 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 11.36 | 17929310 | |
| MESH:D020258 | Neurotoxicity Syndromes | Disulfiram | 8.33 | 11005259 | |
| MESH:D020258 | Neurotoxicity Syndromes | Fluorouracil | 8.33 | 16436463 | |
| MESH:D020258 | Neurotoxicity Syndromes | Glyburide | 8.33 | 16725203 | |
| MESH:D009503 | Neutropenia | Cyclophosphamide | 9.32 | 8291058 | |
| MESH:D009503 | Neutropenia | Folic Acid | 9.32 | 16322990 | |
| MESH:D009503 | Neutropenia | Vinblastine | 9.32 | 17378895 | |
| MESH:D009765 | Obesity | Curcumin | 3.45 | 19297423 | |
| MESH:D009765 | Obesity | Plant Extracts | 3.45 | 20132043 19056576 | |
| MESH:D009771 | Obsessive-Compulsive Disorder | venlafaxine | 4.56 | 17503984 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 3.96 | 6374098 | |
| MESH:D009784 | Occupational Diseases | 2,6-dinitrotoluene | 5.33 | 16049721 | |
| MESH:D009784 | Occupational Diseases | 4,4'-diaminodiphenylmethane | 5.33 | 4026338 6482804 | |
| MESH:D009845 | Oligospermia | Cyclophosphamide | 3.53 | 16517039 | |
| MESH:D009902 | Optic Neuritis | 4,4'-diaminodiphenylmethane | 3.80 | 3988306 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 5.10 | 7009135 | |
| MESH:D010003 | Osteoarthritis | Iron | 5.10 | 16640825 | |
| MESH:D010014 | Osteolysis | Paclitaxel | 3.79 | 15867366 | |
| MESH:D010024 | Osteoporosis | Curcumin | 16.40 | 18719352 | |
| MESH:D010024 | Osteoporosis | Genistein | 16.40 | 19401787 | |
| MESH:D010024 | Osteoporosis | Iron | 16.40 | 16640825 16648989 | |
| MESH:D010024 | Osteoporosis | Isoflavones | 16.40 | 16562857 | |
| MESH:D010024 | Osteoporosis | kaempferol | 16.40 | 16756079 | |
| MESH:D010024 | Osteoporosis | Raloxifene | 16.40 | 15775268 17882678 19059307 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Genistein | 14.93 | 16169203 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Quercetin | 14.93 | 19495926 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | Raloxifene | 14.93 | 15758505 17823083 15579764 17893378 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 14.93 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Disulfiram | 6.94 | 18047805 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 6.94 | 15930896 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 29.02 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | arsenic trioxide | 29.02 | 16624393 19769630 12452020 | |
| MESH:D010051 | Ovarian Neoplasms | Cisplatin | 29.02 | 19769630 15464296 6897625 17225452 | |
| MESH:D010051 | Ovarian Neoplasms | Curcumin | 29.02 | 18462866 19020741 | |
| MESH:D010051 | Ovarian Neoplasms | Disulfiram | 29.02 | 17026967 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 29.02 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Genistein | 29.02 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Luteolin | 29.02 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | Paclitaxel | 29.02 | 11161223 | |
| MESH:D010051 | Ovarian Neoplasms | Quercetin | 29.02 | 19005980 | |
| MESH:D010051 | Ovarian Neoplasms | sodium arsenite | 29.02 | 15276417 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 29.02 | 16211241 | |
| MESH:D010146 | Pain | Acetaminophen | 16.64 | 16870215 | |
| MESH:D010146 | Pain | Cyclophosphamide | 16.64 | 12161096 18093676 | |
| MESH:D010146 | Pain | Indomethacin | 16.64 | 17627676 17440234 3291741 13679232 | |
| MESH:D010146 | Pain | montelukast | 16.64 | 15935457 | |
| MESH:D010146 | Pain | Sulindac | 16.64 | 3291741 | |
| MESH:D010146 | Pain | zafirlukast | 16.64 | 11438310 15935457 | |
| MESH:D010146 | Pain | zileuton | 16.64 | 15935457 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 3.48 | 18702446 12538197 | |
| MESH:D010190 | Pancreatic Neoplasms | arsenic trioxide | 24.36 | 15580305 | |
| MESH:D010190 | Pancreatic Neoplasms | Cisplatin | 24.36 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Curcumin | 24.36 | 19401701 17440100 19196508 | |
| MESH:D010190 | Pancreatic Neoplasms | Cyclophosphamide | 24.36 | 11332152 | |
| MESH:D010190 | Pancreatic Neoplasms | Etoposide | 24.36 | 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Fluorouracil | 24.36 | 16500647 16929163 15113037 19003803 | |
| MESH:D010190 | Pancreatic Neoplasms | Mitomycin | 24.36 | 15113037 | |
| MESH:D010190 | Pancreatic Neoplasms | Quercetin | 24.36 | 16965848 | |
| MESH:D010190 | Pancreatic Neoplasms | Sulindac | 24.36 | 11504793 16820089 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 24.36 | 15976015 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 5.46 | 17883296 15028970 | |
| MESH:D010195 | Pancreatitis | zafirlukast | 5.46 | 15028970 | |
| MESH:D016584 | Panic Disorder | Ethinyl Estradiol | 2.56 | 11578682 | |
| MESH:D010212 | Papilloma | 4,4'-diaminodiphenylmethane | 12.83 | 7296757 | |
| MESH:D010212 | Papilloma | Iron | 12.83 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 12.83 | 16517061 15173996 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 12.83 | 12065085 8330346 18922899 18404319 | |
| MESH:D010235 | Paraganglioma | arsenic trioxide | 3.04 | 19927285 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.50 | 16537180 | |
| MESH:D020447 | Parasomnias | Iron | 4.80 | 17352947 | |
| MESH:D010300 | Parkinson Disease | Iron | 2.77 | 16640825 16563566 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 3.06 | 12349958 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.50 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | 1-Naphthylisothiocyanate | 9.78 | 20133375 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 9.78 | 12520081 | |
| MESH:D010409 | Penile Diseases | Antimony | 4.57 | 9643325 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 3.96 | 11148446 | |
| MESH:D010493 | Pericarditis | Antimony | 4.92 | 20465667 | |
| MESH:D010518 | Periodontitis | Indomethacin | 3.71 | 17225004 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 6.29 | 16093927 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Cisplatin | 6.29 | 15464296 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 9.14 | 16905509 6392382 15371236 | |
| MESH:D016491 | Peripheral Vascular Diseases | Cadmium | 9.14 | 15687053 | |
| MESH:D010538 | Peritonitis | Ozone | 6.70 | 16369182 | |
| MESH:D010538 | Peritonitis | zileuton | 6.70 | 17371808 | |
| MESH:D010612 | Pharyngitis | zafirlukast | 5.52 | 10386485 9377612 | |
| MESH:D010787 | Photosensitivity Disorders | 4,4'-diaminodiphenylmethane | 8.99 | 6228378 | |
| MESH:D010787 | Photosensitivity Disorders | 4-hydroxy-2-nonenal | 8.99 | 11550810 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 3.94 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Iron | 4.46 | 16604332 | |
| MESH:D010997 | Pleural Neoplasms | Cisplatin | 9.93 | 17638057 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 9.93 | 17638057 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 7.18 | 12224865 11605937 | |
| MESH:D011014 | Pneumonia | Ozone | 7.18 | 18007984 18929643 18381685 | |
| MESH:D011015 | Pneumonia, Aspiration | Nitric Oxide | 4.15 | 18573544 | |
| MESH:D011041 | Poisoning | Iron | 3.21 | 16604332 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Iron | 7.22 | 16640825 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 7.22 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 5.61 | 12371664 | |
| MESH:D011230 | Precancerous Conditions | Quercetin | 5.61 | 19056647 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cyclophosphamide | 14.38 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Cytarabine | 14.38 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Daunorubicin | 14.38 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 14.38 | 21297632 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Vincristine | 14.38 | 21297632 | |
| MESH:D011225 | Pre-Eclampsia | Iron | 3.43 | 16640825 | |
| MESH:D047928 | Premature Birth | Indomethacin | 3.95 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 9.50 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 9.50 | 11222880 11118676 11896295 11399792 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Valproic Acid | 9.50 | 20603192 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 7.20 | 20887781 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Testosterone | 7.20 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | Apigenin | 13.61 | 17132221 | |
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 13.61 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | arsenic trioxide | 13.61 | 19131511 | |
| MESH:D011471 | Prostatic Neoplasms | biochanin A | 13.61 | 12111696 | |
| MESH:D011471 | Prostatic Neoplasms | Cadmium | 13.61 | 17075824 | |
| MESH:D011471 | Prostatic Neoplasms | Curcumin | 13.61 | 11398177 18156803 18769126 15129424 10851300 12497104 18226269 | |
| MESH:D011471 | Prostatic Neoplasms | Cyclophosphamide | 13.61 | 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Disulfiram | 13.61 | 19789329 | |
| MESH:D011471 | Prostatic Neoplasms | docetaxel | 13.61 | 16520278 18824434 16644109 19103299 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 13.61 | 15749863 15897917 16868541 16888761 16729912 18437689 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 13.61 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Etoposide | 13.61 | 17172428 | |
| MESH:D011471 | Prostatic Neoplasms | Fluorouracil | 13.61 | 19082440 18626508 | |
| MESH:D011471 | Prostatic Neoplasms | Genistein | 13.61 | 16925846 15256057 15378649 | |
| MESH:D011471 | Prostatic Neoplasms | Isoflavones | 13.61 | 17374662 17219775 17571952 16365062 | |
| MESH:D011471 | Prostatic Neoplasms | Melphalan | 13.61 | 15749863 | |
| MESH:D011471 | Prostatic Neoplasms | Paclitaxel | 13.61 | 17136230 17172428 16729912 16356831 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 13.61 | 14666653 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | Quercetin | 13.61 | 14715546 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Raloxifene | 13.61 | 16536755 16220300 15731164 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 13.61 | 16731767 17675339 15767336 17718901 17636462 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | sodium arsenite | 13.61 | 16039940 | |
| MESH:D011471 | Prostatic Neoplasms | Tamoxifen | 13.61 | 15067354 | |
| MESH:D011471 | Prostatic Neoplasms | Tocopherols | 13.61 | 12504091 | |
| MESH:D011507 | Proteinuria | Arsenic | 5.80 | 21343184 | |
| MESH:D011507 | Proteinuria | Indomethacin | 5.80 | 11849393 | |
| MESH:D011528 | Protozoan Infections | Iron | 4.80 | 16640825 | |
| MESH:D011537 | Pruritus | Ethinyl Estradiol | 6.02 | 16919318 15861022 | |
| MESH:D011537 | Pruritus | zileuton | 6.02 | 17827870 19657356 | |
| MESH:D019310 | Pseudolymphoma | Valproic Acid | 3.33 | 11422049 12752131 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 3.83 | 16882103 | |
| MESH:D011565 | Psoriasis | Methotrexate | 3.83 | 17410198 | |
| MESH:D011595 | Psychomotor Agitation | Haloperidol | 3.79 | 11575062 | |
| MESH:D011618 | Psychotic Disorders | Haloperidol | 3.30 | 11575062 | |
| MESH:D029424 | Pulmonary Disease, Chronic Obstructive | zafirlukast | 4.21 | 12877822 12781059 | |
| MESH:D011654 | Pulmonary Edema | zafirlukast | 7.63 | 18309904 | |
| MESH:D011654 | Pulmonary Edema | zileuton | 7.63 | 18309904 | |
| MESH:D011656 | Pulmonary Emphysema | Curcumin | 3.44 | 19168576 | |
| MESH:D011658 | Pulmonary Fibrosis | Cyclophosphamide | 2.69 | 16636934 | |
| MESH:D011693 | Purpura | Raloxifene | 4.34 | 15770314 | |
| MESH:D012004 | Rectal Neoplasms | Fluorouracil | 2.95 | 15538739 16160472 18286688 18722050 | |
| MESH:D000608 | Renal Aminoacidurias | Mercuric Chloride | 4.89 | 2918855 | |
| MESH:D051437 | Renal Insufficiency | Cisplatin | 15.03 | 15464296 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 15.03 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Folic Acid | 15.03 | 15728788 | |
| MESH:D051437 | Renal Insufficiency | Methotrexate | 15.03 | 17352296 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.37 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | Leukotriene C4 | 9.50 | 12967936 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 9.50 | 16317513 16314181 17058453 15827377 17520802 | |
| MESH:D015427 | Reperfusion Injury | zafirlukast | 9.50 | 12967936 | |
| MESH:D015427 | Reperfusion Injury | zileuton | 9.50 | 15266012 9865762 | |
| MESH:D012120 | Respiration Disorders | Chlorine | 4.00 | 18579056 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Acetylcysteine | 8.94 | 12210543 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Curcumin | 8.94 | 10666014 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 8.94 | 18379247 11700416 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 2.83 | 10835634 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.69 | 18990726 | |
| MESH:D012148 | Restless Legs Syndrome | Iron | 3.56 | 16930377 | |
| MESH:D012162 | Retinal Degeneration | 4,4'-diaminodiphenylmethane | 2.40 | 3692021 | |
| MESH:D012208 | Rhabdomyosarcoma | Valproic Acid | 3.05 | 19155313 | |
| MESH:D012220 | Rhinitis | montelukast | 8.80 | 20332717 | |
| MESH:D012220 | Rhinitis | zafirlukast | 8.80 | 7767514 20332717 12742009 | |
| MESH:D012220 | Rhinitis | zileuton | 8.80 | 20332717 | |
| MESH:D012221 | Rhinitis, Allergic, Perennial | Chlorpheniramine | 5.28 | 8201490 10822083 | |
| MESH:D006255 | Rhinitis, Allergic, Seasonal | Chlorpheniramine | 5.51 | 19075512 | |
| MESH:D012509 | Sarcoma | Curcumin | 6.01 | 18462866 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 6.01 | 15625365 18313854 16767912 17203757 17710206 15675481 | |
| MESH:D012512 | Sarcoma, Ewing's | arsenic trioxide | 20.34 | 16646077 | |
| MESH:D012512 | Sarcoma, Ewing's | Cisplatin | 20.34 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Dactinomycin | 20.34 | 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 20.34 | 16326096 14601052 | |
| MESH:D012512 | Sarcoma, Ewing's | Etoposide | 20.34 | 14601052 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.60 | 17846226 | |
| MESH:D012554 | Schistosomiasis japonica | Quercetin | 4.33 | 16862918 | |
| MESH:D012555 | Schistosomiasis mansoni | Nitric Oxide | 4.31 | 9673227 | |
| MESH:D012559 | Schizophrenia | Folic Acid | 3.63 | 16641680 | |
| MESH:D012559 | Schizophrenia | Haloperidol | 3.63 | 20107430 1830565 18513383 19369910 | |
| MESH:D012559 | Schizophrenia | Valproic Acid | 3.63 | 15737665 19110320 | |
| MESH:D012595 | Scleroderma, Systemic | Cyclophosphamide | 3.70 | 16636934 | |
| MESH:D012640 | Seizures | 2,6-dinitrotoluene | 9.08 | 18551238 | |
| MESH:D012640 | Seizures | Isoniazid | 9.08 | 16107249 | |
| MESH:D012640 | Seizures | Pilocarpine | 9.08 | 7750514 19660546 | |
| MESH:D012640 | Seizures | Toluene | 9.08 | 9294310 6431079 | |
| MESH:D012640 | Seizures | Valproic Acid | 9.08 | 16876388 14763951 11738929 3137016 15475178 1511512 17978042 11044598 | |
| MESH:D018805 | Sepsis | Curcumin | 3.05 | 18389075 | |
| MESH:D012735 | Sexual Dysfunction, Physiological | Testosterone | 4.99 | 16631401 | |
| MESH:D012852 | Sinusitis | zafirlukast | 8.00 | 10386485 10665187 | |
| MESH:D012852 | Sinusitis | zileuton | 8.00 | 10665187 | |
| MESH:D012851 | Sinus Thrombosis, Intracranial | Heparin | 4.89 | 12269725 | |
| MESH:D012871 | Skin Diseases | Arsenic | 5.20 | 15952646 18709164 17548696 19834688 17050553 16353154 17453740 17938729 16759981 16702368 6392382 | |
| MESH:D012871 | Skin Diseases | Folic Acid | 5.20 | 18709164 | |
| MESH:D012871 | Skin Diseases | monomethylarsonic acid | 5.20 | 21378128 | |
| MESH:D012878 | Skin Neoplasms | Arsenic | 25.50 | 17976673 17050553 15504454 16251483 19538983 17029826 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 25.50 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Glucose | 25.50 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Iron | 25.50 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Melphalan | 25.50 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 25.50 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 25.50 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | sodium arsenite | 25.50 | 18572023 19524636 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 25.50 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 25.50 | 11807781 12065085 8985016 18404319 8330346 | |
| MESH:D020181 | Sleep Apnea, Obstructive | montelukast | 9.29 | 19118273 | |
| MESH:D020181 | Sleep Apnea, Obstructive | zileuton | 9.29 | 19118273 | |
| MESH:D055752 | Small Cell Lung Carcinoma | Cisplatin | 4.13 | 15464296 | |
| MESH:D012912 | Sneezing | Chlorpheniramine | 5.51 | 19075512 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.40 | 15625365 17203757 16767912 | |
| MESH:D013088 | Spermatocele | Ethinyl Estradiol | 7.56 | 16709447 | |
| MESH:D013088 | Spermatocele | Tamoxifen | 7.56 | 16709447 | |
| OMIM:102530 | SPERMATOGENIC FAILURE 6 | Cyclophosphamide | 4.32 | 16517039 | |
| MESH:D013118 | Spinal Cord Diseases | Folic Acid | 4.30 | 16361298 | |
| MESH:D013119 | Spinal Cord Injuries | montelukast | 12.03 | 18059327 | |
| MESH:D013119 | Spinal Cord Injuries | Tamoxifen | 12.03 | 19457130 | |
| MESH:D013119 | Spinal Cord Injuries | zileuton | 12.03 | 18059327 | |
| MESH:D016135 | Spinal Dysraphism | sodium arsenite | 6.21 | 12854658 | |
| MESH:D016135 | Spinal Dysraphism | Valproic Acid | 6.21 | 19490988 | |
| MESH:D013226 | Status Epilepticus | Pilocarpine | 8.84 | 19430551 11259499 19055492 15857427 19951488 15987249 19570321 | |
| MESH:D013226 | Status Epilepticus | Valproic Acid | 8.84 | 12833885 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 6.46 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 6.46 | 16184426 17207306 18545984 15038085 16113693 15472012 16280098 17160473 10215738 18209964 17638125 10486359 10192188 | |
| MESH:D013274 | Stomach Neoplasms | arsenic trioxide | 9.28 | 17007042 | |
| MESH:D013274 | Stomach Neoplasms | Cisplatin | 9.28 | 18396642 15958060 17522103 | |
| MESH:D013274 | Stomach Neoplasms | docetaxel | 9.28 | 16557585 | |
| MESH:D013274 | Stomach Neoplasms | Fluorouracil | 9.28 | 17498489 17522103 17172411 18567086 19015929 18396642 19084572 16424979 15786421 16951190 | |
| MESH:D013274 | Stomach Neoplasms | Folic Acid | 9.28 | 17171786 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 9.28 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | irinotecan | 9.28 | 15723263 | |
| MESH:D013274 | Stomach Neoplasms | Paclitaxel | 9.28 | 18396642 18506536 | |
| MESH:D013274 | Stomach Neoplasms | Sodium Chloride | 9.28 | 16646055 | |
| MESH:D013276 | Stomach Ulcer | Acetylcysteine | 21.06 | 17918041 | |
| MESH:D013276 | Stomach Ulcer | bis(4-hydroxycinnamoyl)methane | 21.06 | 19188055 | |
| MESH:D013276 | Stomach Ulcer | Curcumin | 21.06 | 16631530 19188055 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 21.06 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 21.06 | 17135157 11595415 11145282 18237397 15138204 11523592 18299717 17657623 18087811 15255614 15104355 16252198 16755016 18193104 12467913 12500499 16150113 16169175 11729361 12787963 14567935 17654042 16397915 18726076 12077510 1323529 10750652 17895592 18543354 10423059 12498302 16934674 18431645 18209962 16631530 11906479 11595431 17918041 18181030 17627676 10878458 17977527 | |
| MESH:D013276 | Stomach Ulcer | montelukast | 21.06 | 17895592 | |
| MESH:D013276 | Stomach Ulcer | Nitric Oxide | 21.06 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 21.06 | 18193104 15255614 12787963 17135157 18237397 | |
| MESH:D020521 | Stroke | Folic Acid | 5.65 | 16517955 | |
| MESH:D020521 | Stroke | Raloxifene | 5.65 | 16837676 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.40 | 16321402 | |
| MESH:D013398 | Sudden Infant Death | Iron | 4.26 | 16640825 | |
| MESH:D015173 | Supratentorial Neoplasms | Cyclophosphamide | 13.76 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Thiotepa | 13.76 | 12837982 | |
| MESH:D015173 | Supratentorial Neoplasms | Vincristine | 13.76 | 12837982 | |
| MESH:D013576 | Syndactyly | Methotrexate | 3.89 | 9562676 | |
| MESH:D017180 | Tachycardia, Ventricular | Haloperidol | 3.57 | 20210726 | |
| MESH:D024801 | Tauopathies | Camptothecin | 12.56 | 16930453 | |
| MESH:D024801 | Tauopathies | Daunorubicin | 12.56 | 16930453 | |
| MESH:D024801 | Tauopathies | Paclitaxel | 12.56 | 16930453 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 9.27 | 17997062 | |
| MESH:D013705 | Temporomandibular Joint Disorders | polyphenols | 9.27 | 17997062 | |
| MESH:D013733 | Testicular Diseases | Toluene | 3.78 | 10048760 10514026 | |
| MESH:D013736 | Testicular Neoplasms | Cisplatin | 3.51 | 17225452 15464296 | |
| MESH:D013921 | Thrombocytopenia | 1-Naphthylisothiocyanate | 10.26 | 20133375 | |
| MESH:D013921 | Thrombocytopenia | Heparin | 10.26 | 16651880 16893407 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 10.26 | 15821434 | |
| MESH:D019851 | Thrombophilia | Ethinyl Estradiol | 2.50 | 11994571 | |
| MESH:D013927 | Thrombosis | Ethinyl Estradiol | 6.00 | 15669648 | |
| MESH:D013927 | Thrombosis | Heparin | 6.00 | 16893407 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 2.69 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | 4,4'-diaminodiphenylmethane | 9.14 | 1399818 6582329 3712494 7505956 6587162 | |
| MESH:D013964 | Thyroid Neoplasms | arsenic trioxide | 9.14 | 19014326 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 9.14 | 17909728 16010429 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 9.14 | 11352223 14736730 18791128 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 9.70 | 19048282 | |
| MESH:D013978 | Tibial Fractures | Raloxifene | 9.70 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | 4-Nitroquinoline-1-oxide | 10.72 | 16543248 | |
| MESH:D014062 | Tongue Neoplasms | Fluorouracil | 10.72 | 16280240 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 10.72 | 16227395 | |
| MESH:D016171 | Torsades de Pointes | arsenic trioxide | 2.79 | 15213294 | |
| MESH:D014178 | Translocation, Genetic | Valproic Acid | 4.02 | 17262798 | |
| MESH:D014202 | Tremor | Pilocarpine | 4.61 | 17594079 | |
| MESH:D014352 | Trypanosomiasis | Antimony | 4.72 | 15220340 | |
| MESH:D014376 | Tuberculosis | Iron | 8.60 | 16597321 | |
| MESH:D014376 | Tuberculosis | Isoniazid | 8.60 | 18397238 15673755 17950035 16770646 15236969 17720495 | |
| MESH:D014376 | Tuberculosis | Rifampin | 8.60 | 18397238 15236969 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.71 | 10574470 17380554 | |
| MESH:D020194 | Unverricht-Lundborg Syndrome | Valproic Acid | 3.33 | 3119515 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2,6-dinitrotoluene | 35.93 | 16049721 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 2-Acetylaminofluorene | 35.93 | 15289314 1399818 15867355 | |
| MESH:D001749 | Urinary Bladder Neoplasms | 4,4'-diaminodiphenylmethane | 35.93 | 8074119 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 35.93 | 11144890 19429237 19322015 18640142 17976673 15987713 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | arsenic trioxide | 35.93 | 12845720 20435036 11780464 12973940 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cacodylic Acid | 35.93 | 15537745 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cisplatin | 35.93 | 15464296 17225452 12973940 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Curcumin | 35.93 | 18593936 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Cyclophosphamide | 35.93 | 14692829 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 35.93 | 17653716 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Quercetin | 35.93 | 16720314 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Raloxifene | 35.93 | 17572228 | |
| MESH:D001749 | Urinary Bladder Neoplasms | sodium arsenite | 35.93 | 16712894 17306315 11723127 16452187 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Tamoxifen | 35.93 | 17572228 8653321 16712894 | |
| MESH:D014564 | Urogenital Abnormalities | Valproic Acid | 3.47 | 8888407 | |
| MESH:D014565 | Urogenital Neoplasms | Curcumin | 4.07 | 18462866 | |
| MESH:D014571 | Urologic Neoplasms | 2,6-dinitrotoluene | 3.13 | 10091137 | |
| MESH:D014581 | Urticaria | Acetaminophen | 12.18 | 10982225 | |
| MESH:D014581 | Urticaria | Chlorpheniramine | 12.18 | 2569998 | |
| MESH:D014581 | Urticaria | montelukast | 12.18 | 10982225 | |
| MESH:D014581 | Urticaria | zafirlukast | 12.18 | 14512923 14713918 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Cisplatin | 18.43 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Fluorouracil | 18.43 | 16803524 | |
| MESH:D002583 | Uterine Cervical Neoplasms | indole-3-carbinol | 18.43 | 16082211 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 18.43 | 17473185 | |
| MESH:D002583 | Uterine Cervical Neoplasms | sodium arsenite | 18.43 | 11813266 | |
| MESH:D014594 | Uterine Neoplasms | Ethinyl Estradiol | 9.60 | 14692618 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 9.60 | 17044934 | |
| MESH:D014594 | Uterine Neoplasms | Sulindac | 9.60 | 18645019 | |
| MESH:D014605 | Uveitis | Cyclosporine | 7.77 | 1336536 | |
| MESH:D014605 | Uveitis | Dexamethasone | 7.77 | 1336536 | |
| MESH:D014625 | Vaginal Neoplasms | Cisplatin | 7.44 | 15577323 | |
| MESH:D014625 | Vaginal Neoplasms | Vinblastine | 7.44 | 15577323 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 7.91 | 17056641 | |
| MESH:D014652 | Vascular Diseases | sodium arsenite | 7.91 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.38 | 12125929 | |
| MESH:D014657 | Vasculitis | Heparin | 8.94 | 20337814 | |
| MESH:D014657 | Vasculitis | zafirlukast | 8.94 | 12189465 | |
| MESH:D054556 | Venous Thromboembolism | Raloxifene | 4.00 | 16837676 | |
| MESH:D020246 | Venous Thrombosis | Ethinyl Estradiol | 2.44 | 14671159 15869587 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 10.56 | 17678736 16364871 17638931 17334414 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 10.56 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 10.56 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 4.12 | 18097624 | |
| MESH:D014839 | Vomiting | Cisplatin | 7.54 | 11897121 | |
| MESH:D014839 | Vomiting | Indomethacin | 7.54 | 11897121 | |
| MESH:D014846 | Vulvar Neoplasms | Raloxifene | 4.34 | 16343187 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.04 | 15886252 | |
| MESH:D014947 | Wounds and Injuries | Estrogens | 5.80 | 11172683 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 5.80 | 19894650 20213670 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 3.23 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:02010 | ABC transporters |
| REACT:15314 | Hormone biosynthesis |
| REACT:22258 | Metabolism of lipids and lipoproteins |
| KEGG:04977 | Vitamin digestion and absorption |
| Releated gene ID | Related gene Name |
|---|---|
| PA244 | ABCC1 |
| Releated disease ID | Related disease Name |
|---|---|
| PA445062 | Neoplasms |
| PA443796 | Coronary Artery Disease |
| PA444516 | Hypercholesterolemia |
| PA443434 | Arthritis, Rheumatoid |
| PA445113 | Neutropenia |
| PA444845 | Lymphoma, Non-Hodgkin |
| PA447178 | Pulmonary Disease, Chronic Obstructive |
| PA444750 | Leukemia |
| PA446171 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
| PA445451 | Psoriasis |
| PA443450 | Asthma |
| PA443265 | Adenocarcinoma |
| PA443557 | Brain Neoplasms |
| PA443756 | Colonic Neoplasms |
| PA444840 | Lymphoma |
| PA444903 | Melanoma |
| PA445204 | Ovarian Neoplasms |
| PA445425 | Prostatic Neoplasms |
| PA444818 | Lung Neoplasms |
| PA443890 | Diabetes Mellitus, Type 2 |
| PA444761 | Leukemia, Myeloid |
| PA444760 | Leukemia, Myeloid, Acute |
| PA443421 | Arrhythmias, Cardiac |
| PA445018 | Cardiomyopathies |
| PA443937 | Drug Toxicity |
| PA443340 | Anemia |
| PA444773 | Leukopenia |
| PA445846 | Thrombocytopenia |
| Releated drug ID | Related drug Name |
|---|---|
| PA450085 | irinotecan |
| PA165110775 | SN-38 |
| PA450163 | lamivudine |
| PA449319 | digoxin |
| PA449014 | cisplatin |
| PA448500 | atorvastatin |
| PA449412 | doxorubicin |
| PA450191 | lecithin |
| PA451955 | zileuton |
| PA449789 | glycine |
| PA449780 | glutathione |
| PA449383 | docetaxel |
| PA448803 | carboplatin |
| PA450428 | methotrexate |
| PA449692 | folic acid |
| PA450198 | leucovorin |
| PA449552 | etoposide |
| PA448926 | chlorambucil |
| PA450526 | mitoxantrone |
| PA451879 | vincristine |
| PA449092 | colchicine |
| PA449212 | daunorubicin |
| PA449476 | epirubicin |
| PA450761 | paclitaxel |
| PA451877 | vinblastine |
| PA449177 | cytarabine |
| PA450546 | montelukast |
| PA452621 | antineoplastic agents |
| PA449509 | estrogens |
| PA450085 | irinotecan |
| PA10804 | imatinib |
| PA449782 | glibenclamide |
| PA449503 | estradiol |
| PA449512 | estrone |
| PA130620651 | anthracyclines and related substances |
| PA164924560 | Biricodar |
| PA132595336 | calcein |
| PA448810 | carmustine |
| PA449518 | ethacrynic acid |
| PA165109660 | genistein |
| PA449961 | idarubicin |
| PA164712813 | Imidazothiazole derivatives |
| PA449982 | indomethacin |
| PA165109661 | MK-571 |
| PA451106 | probenecid |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB01138 | antagonist | Sulfinpyrazone | Uricosuric Agents |
| No data |
| Drugbank ID | Action | Drug Name | Description |
|---|---|---|---|
| DB00091 | inhibitor | Cyclosporine | Antirheumatic Agents;Immunomodulatory Agents;Enzyme Inhibitors;Dermatologic Agents;Immunosuppressive Agents;Antifungal Agents |
| DB00143 | inhibitor | BSS Plus | Dietary supplement;Micronutrient |
| DB00199 | inhibitor | T-Stat Pad-Lot | Anti-Bacterial Agents;Macrolides |
| DB00224 | inhibitor | Indinavir | Anti-HIV Agents;HIV Protease Inhibitors |
| DB00286 | inhibitor | Prempro | Estrogens |
| DB00328 | inhibitor | Indomethacin | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Tocolytic Agents;Cardiovascular Agents;Nonsteroidal Anti-inflammatory Agents (NSAIAs);Gout Suppressants |
| DB00345 | substrate | Aminohippurate | Diagnostic aids;Indicators and Reagents |
| DB00365 | substrate | Grepafloxacin | Anti-Infectives;Anti-Bacterial Agents;Quinolones;Antibiotics |
| DB00396 | inhibitor | Synovex S | Contraceptives;Progestins |
| DB00399 | substrate | Zoledronate | Antihypocalcemic Agents;Bisphosphonates;Antiresorptives;Bone Density Conservation Agents |
| DB00445 | substrate | Epirubicin | Antineoplastic Agents;Antibiotics, Antineoplastic |
| DB00503 | inducer | Kaletra | Anti-HIV Agents;HIV Protease Inhibitors |
| DB00541 | inhibitor | Vincristine | Antineoplastic Agents;Antineoplastic Agents, Phytogenic;Tubulin Modulators |
| DB00563 | inhibitor | Methotrexate | Antineoplastic Agents;Antirheumatic Agents;Antimetabolites;Enzyme Inhibitors;Folic Acid Antagonists;Dermatologic Agents;Immunosuppressive Agents;Nucleic Acid Synthesis Inhibitors;Abortifacient Agents, Nonsteroidal;Abortifacient Agents;Antimetabolites, Antineoplastic |
| DB00570 | inducer | Vinblastine | Antineoplastic Agents, Phytogenic;Tubulin Modulators |
| DB00586 | inhibitor | Diclofenac | Cyclooxygenase Inhibitors;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB00602 | inhibitor | Heel 170 Tab | Anthelmintics;Antiprotozoal Agents;Antinematodal Agents |
| DB00661 | inhibitor | Tarka | Vasodilator Agents;Antiarrhythmic Agents;Calcium Channel Blockers;Anti-Arrhythmia Agents |
| DB00693 | substrate | Fluress Liq Oph | Contrast Media;Fluorescent Dyes |
| DB00694 | inhibitor | Daunorubicin | Antineoplastic Agents;Antibiotics;Antibiotics, Antineoplastic |
| DB00701 | inhibitor | Amprenavir | Anti-HIV Agents;HIV Protease Inhibitors;Antibiotics, Antitubercular |
| DB00709 | inhibitor | Trizivir | Anti-HIV Agents;Nucleoside and Nucleotide Reverse Transcriptase Inhibitors;Reverse Transcriptase Inhibitors |
| DB00762 | substrate | Irinotecan | Antineoplastic Agents;Radiation-Sensitizing Agents;Parasympathomimetics;Enzyme Inhibitors;Prodrugs;Antineoplastic Agents, Phytogenic |
| DB00773 | inhibitor | Etoposide | Nucleic Acid Synthesis Inhibitors;Antineoplastic Agents, Phytogenic |
| DB00834 | inhibitor | Mifepristone | Contraceptives, Oral, Synthetic;Menstruation-Inducing Agents;Luteolytic Agents;Contraceptives, Postcoital, Synthetic;Hormone Antagonists;Abortifacient Agents, Steroidal |
| DB00970 | substrate | Dactinomycin | Antineoplastic Agents;Anti-Bacterial Agents;Nucleic Acid Synthesis Inhibitors;Antibiotics;Antibiotics, Antineoplastic;Protein Synthesis Inhibitors |
| DB00997 | inhibitor | Doxorubicin | Antineoplastic Agents;Antibiotics;Antibiotics, Antineoplastic |
| DB01016 | inhibitor | Glucovance | Hypoglycemic Agents;Antiarrhythmic Agents;Sulfonylureas |
| DB01032 | inhibitor | Probenecid | Uricosuric Agents;Adjuvants, Pharmaceutic |
| DB01045 | inhibitor | Rifater | Enzyme Inhibitors;Antituberculosis Agents;Nucleic Acid Synthesis Inhibitors;Leprostatic Agents;Antibiotics;Antibiotics, Antitubercular |
| DB01050 | inhibitor | Vicoprofen® | Anti-inflammatory Agents;Cyclooxygenase Inhibitors;Analgesics;Analgesics, Non-Narcotic;Antipyretics;Nonsteroidal Anti-inflammatory Agents (NSAIAs) |
| DB01072 | inhibitor | Atazanavir | Anti-HIV Agents;Protease Inhibitors;HIV Protease Inhibitors |
| DB01076 | substrate | Caduet | Anticholesteremic Agents;HMG-CoA Reductase Inhibitors;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| DB01098 | substrate | Rosuvastatin | Anticholesteremic Agents;HMG-CoA Reductase Inhibitors;Hydroxymethylglutaryl-CoA Reductase Inhibitors |
| DB01138 | inhibitor | Sulfinpyrazone | Uricosuric Agents |
| DB01165 | inhibitor | Ofloxacin | Anti-Infectives;Anti-Bacterial Agents;Quinolones;Nucleic Acid Synthesis Inhibitors;Anti-Infective Agents, Urinary |
| DB01174 | inducer | Phenobarbital | Hypnotics and Sedatives;Anticonvulsants;GABA Modulators;Excitatory Amino Acid Antagonists |
| DB01177 | inhibitor | Idarubicin | Antineoplastic Agents;Antibiotics;Antibiotics, Antineoplastic |
| DB01204 | inhibitor | Mitoxantrone | Antineoplastic Agents;Analgesics |
| DB01229 | inhibitor | Paclitaxel | Antineoplastic Agents;Antineoplastic Agents, Phytogenic;Tubulin Modulators |
| DB01232 | substrate | Saquinavir | Anti-HIV Agents;HIV Protease Inhibitors |
| DB01394 | substrate | Sucurnix HP | Gout Suppressants;Tubulin Modulators |
| DB01645 | inhibitor | Genistein | Antineoplastic Agents;Enzyme Inhibitors;Growth Inhibitors;Anticarcinogenic Agents;Protein Kinase Inhibitors;Phytoestrogens |
| DB02375 | inhibitor | Myricetin | |
| DB02659 | inducer | Cholic Acid | |
| DB03467 | inhibitor | Naringenin | Anti-Ulcer Agents;Estrogen Antagonists |
| DB03825 | substrate | Rhodamine 6g | Antineoplastic Agents;Fluorescent Dyes |
| DB04216 | inducer | Quercetin | Antioxidants |
| DB04348 | inducer | Taurocholic Acid | Cholagogues and Choleretics;Detergents |
| No data |